Cyclosporin A (NSC 290193)

For research use only. Not for use in humans.

目录号:S2286 别名: Cyclosporine A, Cyclosporine, Ciclosporin, CsA 中文名称:环孢菌素A

Cyclosporin A (NSC 290193) Chemical Structure

CAS No. 59865-13-3

Cyclosporin A (NSC 290193, Cyclosporine A, Cyclosporine, Ciclosporin, CsA)是一种免疫抑制剂,与亲环素结合,随后抑制calcineurin,无细胞试验中IC50为7 nM,广泛用于预防器官移植反应中的排斥反应。

规格 价格 库存 购买数量  
10mM (1mL in DMSO) RMB 1073.15 现货
RMB 786.07 现货
RMB 1957.41 现货
有超大折扣
今日订购,明日送达 全国免运费 分装免费
全国免费电话:400-668-6834   |   Email:info@selleck.cn

客户使用Selleck生产的Cyclosporin A (NSC 290193)发表文献60篇:

产品安全说明书

Antineoplastic and Immunosuppressive Antibiotics抑制剂选择性比较

生物活性

产品描述 Cyclosporin A (NSC 290193, Cyclosporine A, Cyclosporine, Ciclosporin, CsA)是一种免疫抑制剂,与亲环素结合,随后抑制calcineurin,无细胞试验中IC50为7 nM,广泛用于预防器官移植反应中的排斥反应。
靶点
calcineurin [1]
(Cell-free assay)
7 nM
体外研究

在T细胞中,Cyclosporin A与亲环蛋白(免疫亲和素)结合[1],形成亲环蛋白-Cyclosporin A复合体,其结合并抑制钙调磷酸酶。[2]Cyclosporin A 抑制钙调磷酸酶,IC50 是7 nM[3],随后阻断NF-AT核转运。 [4]Cyclosporin A通过抑制MTP(线粒体通透性转换孔)的开放而影响线粒体,IC50 是39 nM。[5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
rat H42E cells M3jVbmN6fG:2b4jpZ:Kh[XO|YYm= MYrDfZRwfG:6aXPpeJkh[WejaX7zeEBz[XRiSESySUBk\WyuczDhd5Nme3OnZDDhd{BqdnS{YXPlcIx2dGG{IFHUVEBt\X[nbDygWGM2OD12MjFOwG0> NHr4c|M9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUWwNlA2QCd-MUm1NFIxPTh:L3G+
mouse L929 cells NEHwWWpEgXSxdH;4bYPDqGG|c3H5 NFfNdXY{KGSjeYO= NH;obHFEgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBNQTJ7IHPlcIx{KGGodHXyJFMh\GG7czDifUBOXFNiYYPzZZktKEmFNUC9N|Ah|ryP NYjCcHBFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW5PFUyQTVpPkK1PVg2OTl3PD;hQi=>
human Huh-Mono cells MkTQR5l1d3SxeHnjxsBie3OjeR?= MljpN{Bl[Xm| NFXI[GtEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJfWhvTX;uc{Bk\WyuczDh[pRmeiB|IHThfZMh[nliTWTUJIF{e2G778{MJGNEPTB;MkSg{txO M{XyRlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NkK1O|Y3Lz5zOE[yOVc3PjxxYU6=
MDCK cells NH;GdXNEgXSxdH;4bYPDqGG|c3H5 NVu4UG41S3m2b4TvfIlkcXS7IHHnZYlve3RiTVTDT{Bk\WyuczygWGM2OD17Lkmg{txO M1jYZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6MkGyNVAxLz5zOEKxNlExODxxYU6=
human LCC-6 cells NYrKNoNwS3m2b4TvfIlkyqCjc4PhfS=> NV61VWZ1PzJiaB?= MV7DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDMR2MuPiClZXzsd{Bi\nSncjC3NkBpenNuIFnDOVA:QC5|IN88US=> MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjN{MESwNkc,OjJ|MkC0NFI9N2F-
human HeLa cells MXnDfZRwfG:6aXRCpIF{e2G7 MXrDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDI[WxiKGOnbHzzMEBVSzVyPUiuN{DPxE1? NH3NWVY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEKxNlExOCd-MUiyNVIyODB:L3G+
african green monkey Vero cells MlrmSpVv[3Srb36gZZN{[Xl? MljaNlQhcA>? NVfHb|dDSW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhX2W|dDDObYxmKH[rcoXzJIlv\mWldHXkJIlvKGGocnnjZY4h\3KnZX6gcY9vc2W7IG\ldo8h[2WubIOgZZN{\XO|ZXSgZZMh\GWlcnXhd4UhcW5idnnyZYwhWk6DIIP5cpRp\XOrczDh[pRmeiB{NDDodpMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBKSzVyPUig{txO NVfDOZk1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm0OVEzQDZpPkG5OFUyOjh4PD;hQi=>
human Huh-9-13 cells M3nsT2N6fG:2b4jpZ:Kh[XO|YYm= Moq2N{Bl[Xm| NYHn[lBOS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUHWqLUmtNVMh[2WubIOgZYZ1\XJiMzDkZZl{KGK7IF3UWEBie3Ojef-8kEBESzVyPUeg{txO NVrjNokyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi2NlU4PjZpPkG4OlI2PzZ4PD;hQi=>
human HuH6 cells MVrDfZRwfG:6aXRCpIF{e2G7 MnT2N{Bl[Xm| NXe4eWZ4S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUHWKNjDj[YxteyCjZoTldkA{KGSjeYOgZpkhVVSWIHHzd4F6NCCFQ{WwQVch|ryP NHPyUYw9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOE[yOVc3Pid-MUi2NlU4PjZ:L3G+
human Huh5-2 cells MX\DfZRwfG:6aXRCpIF{e2G7 NHrBUok{KGSjeYO= MXzDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIeYg2NTJiY3XscJMh[W[2ZYKgN{Bl[Xm|IHL5JG1VXCCjc4PhfUAtKEOFNUC9OkDPxE1? NYr1[3BuRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi2NlU4PjZpPkG4OlI2PzZ4PD;hQi=>
human HuH7 cells M2K3VGN6fG:2b4jpZ:Kh[XO|YYm= NGfQTGJEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBJfUh5IHPlcIx{KGG|c3Xzd4VlKGG|IILlcIVie2Vib3[gcIFkfGG2ZTDk[Yh6\HKxZ3XuZZNmNCCLQ{WwQVUvQDFizszN NX;xboJvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkC5OFM{QTBpPkKwPVQ{OzlyPD;hQi=>
human 2008 cells NGHUOZlHfW6ldHnvckBie3OjeR?= NF;peZNKdmirYnn0bY9vKG:oIHj1cYFvKE2UUEGgbY4hcHWvYX6gNlAxQCClZXzsd{whUUN3ME20Mlc5KM7:TR?= Mn[yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh5MEe4PFQoRjF6N{C3PFg1RC:jPh?=
human HeLa cells NXrPfpU5TnWwY4Tpc44h[XO|YYm= NVnYVJluSW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhUFCYLUG4JIlv\mWldHXkJIlvKGi3bXHuJGhmVGFiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kB3cXKjbDDy[ZBtcWOjdHnvckBi\nSncjC3JIRigXQxvJygWGM2OD12Lk[g{txO M4HtR|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6MkGyNVAxLz5zOEKxNlExODxxYU6=
leukemia CEM cells MlXkSpVv[3Srb36gZZN{[Xl? Mk\oTY5pcWKrdH;yfUBi[3Srdnn0fUBi\2GrboP0JGh2dWGwIF3EVlEhWC2JbInjc5Bzd3SnaX6gRWJEKFS{YX7zdI9zfGW{IIXzbY5oKGyndXvlcYliKEOHTTDj[YxteyxiSVO1NF0{NjRizszN NHTMWXY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMkO2NVM5Pyd-MUKzOlE{QDd:L3G+
human Caco2 cells M2PyU2Z2dmO2aX;uJIF{e2G7 MU\ubIljcXSrb36gc4YhWC2pcDDpckBpfW2jbjDDZYNwOiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6g[Ilod3irbjDl[oZtfXhuIFnDOVA:Oi57IN88US=> M1HybFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|M{iyOFU5Lz5{M{O4NlQ2QDxxYU6=
human MDA435/LCC6MDR cells NH7DcFdEgXSxdH;4bYPDqGG|c3H5 MWG3Nog> MnzUR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWRCPDN3L1zDR|ZOTFJiY3XscJMh\XiycnXzd4lv\yCPRGKgZYZ1\XJiN{KgbJJ{97zOIFnDOVA:Oi56IN88US=> NH7DfFU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkOyNFQxOid-MkKzNlA1ODJ:L3G+
guinea pig ventricular myocytes NVvyXotyTnWwY4Tpc44h[XO|YYm= NUS4V|Q{UW6qaXLpeIlwdiCxZjDMMZR6eGViY3HsZ4l2dSClaHHucoVtKG2nYYP1doVlKHW|aX7nJJdpd2ynLXPlcIwheGG2Y3igZ4xidXBiaX6g[5VqdmWjIIDp[{B3\W62cnnjeYxieiCveX;jfZRmeyxiSVO1NF0zKM7:TR?= M1y3OFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{N{[xNFAxLz5{Mke2NVAxODxxYU6=
KB/MDR cell NYDGNppOTnWwY4Tpc44h[XO|YYm= M1HwSlczKGh? NEi0ZoNKdmirYnn0c5J6KGGldHn2bZR6KGGpYXnud5QhU0JxTVTSJINmdGxibHnu[UBi\nSncjC3NkBpeiCxZjDkdpVoKGW6cH;zeZJmNCCLQ{WwQVEvPSEQvF2= M4HHNlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3NEixPVkyLz5zNUS4NVk6OTxxYU6=
A2780/ADR cells NXK0NodlTnWwY4Tpc44h[XO|YYm= M1vsUmlvcGmkaYTpc44hd2ZiUD3ncJlkd3C{b4TlbY4h\XiycnXzd4VlKGmwIFGyO|gxN0GGUjDj[YxteyCkeTDjZYxk\WmwIFHNJIF{e2G778{MJGlEPTB;MT60NVI2PCEQvF2= MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzh7MEC5OEc,OTd6OUCwPVQ9N2F-
human K562/R7 cells NVKySGI4TnWwY4Tpc44h[XO|YYm= MXSxJO69VQ>? NFvqUoU4OiCq MnXVVI91\W62aXH0bY9vKG:oIHTvfI9zfWKrY3nuMYlv\HWlZXSgZ5l1d3SxeHnjbZR6KGGpYXnud5Qh\G:6b4L1ZolkcW5vcnXzbZN1[W62IHj1cYFvKEt3NkKvVlch[2WubIOgZZN{\XO|ZXSgZZMh\G:6b4L1ZolkcW5iSVO1NEBifCBzIIXNJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTB;MD63JO69VQ>? NGfmN3A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[zOFA1OSd-MkW2N|QxPDF:L3G+
LLC-PK1 epithelial cells Mk\ZSpVv[3Srb36gZZN{[Xl? NFryW3BKdmirYnn0bY9vKG:oIGCt[4x6[2:ycn;0[YlvNCCvb4Xz[UBNNW2mckHiJIV5eHKnc4Pl[EBqdiCOTFOtVGsyKGWyaYTo[Yxq[WxiY3XscJMhfXOrbnegZ4Ft[2Wrbj3BUUBxd2yjcnnzZZRqd25iYYPzZZnwxIxiSVO1NF0xNjdizszN NWT2e|lMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK2PVk{QDlpPkGyOlk6Ozh7PD;hQi=>
mouse L5178 cells NHzGOpVHfW6ldHnvckBie3OjeR?= M3f6dlIxKG2rboO= MWPJcohq[mm2aX;uJI9nKGi3bXHuJGFDS0JzLX3l[IlifGWmIILoc4RidWmwZTCxNlMh\W[obIX4JIlvKG2xdYPlJGw2OTd6IHPlcIx{KGW6cILld5NqdmdiaIXtZY4hVUSUMTDh[pRmeiB{MDDtbY5{KGK7IF\BR3Mh[W6jbInzbZMtKEmFNUC9NE43PSEQvF2= Mn\6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF|NEG3OFUoRjJzM{SxO|Q2RC:jPh?=
KB cell MkXwSpVv[3Srb36gZZN{[Xl? NXT2UHVjUW6qaXLpeI9zgSCjY4Tpeol1gSCjZ3HpcpN1KEuEIHPlcIwhdGmwZTDh[pRmeiB5MjDoJI9nKGS{dXeg[Zhxd3O3cnWsJGlEPTB;MD62JO69VQ>? NH\0SZg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNUS4NVk6OSd-MUW0PFE6QTF:L3G+
mouse mammary carcinoma cell line EMT6/AR 1.0 NUeyNnlTTnWwY4Tpc44h[XO|YYm= Mom1VoV3\XK|YXyg[YZn\WO2IH;uJJRp\SCjY3P1cZVt[XSrb36gc4YhYzOKXT2g[IF2dm:{dXLpZ4lvKGmwIH3veZNmKG2jbX3hdpkh[2G{Y3nuc41iKGOnbHygcIlv\SCHTWS2M2FTKDFwMDygTWM2OD1yLkS0JO69VQ>? NWjq[|duRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUCwPVg3PzFpPkGwNFk5PjdzPD;hQi=>
CK1 cells M{nuWWZ2dmO2aX;uJIF{e2G7 NVzPVmZQSW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhUFCYLUOzJIlv\mWldHXkJIlvKEONMTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKH[rcnHsJJJmeGyrY3H0bY9vKGGodHXyJFch\GG7czygWGM2OD1yLkOg{txO MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDJzMkGwNEc,OTh{MUKxNFA9N2F-
HEK293 cells MlnDSpVv[3Srb36gZZN{[Xl? NW\n[Jg6UW6qaXLpeIlwdiCxZjDPRXRROUJzIDj1cotvd3ewIH;ybYdqdiliZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDwdo91\WmwLX3l[IlifGWmIIDpeIF3[XO2YYTpckB2eHSja3ZvwKwhU2l;MD6yJO69VQ>? NF;KV4Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkW4O|k5Pid-MkK1PFc6QDZ:L3G+
human MDA435/LCC6MDR cells M3fS[mZ2dmO2aX;uJIF{e2G7 NXfaVXZJPSCmYYnz NYjYW4ZzVW:mdXzheIlwdiCxZjDQMYdxKCi3bnvuc5dvKG:{aXfpckkhfHKjboPm[YN1\WRiaX6gbJVu[W5iTVTBOFM2N0yFQ{\NSHIh[2WubIOgZZN{\XO|ZXSgZZMhemW4ZYLzbY5oKHCjY3zpeIF5\WxicnXzbZN1[W6lZTDt[YF{fXKnZDDhd{Bk\WyuIIP1dpZqfmGuIHHmeIVzKDViZHH5d{BjgSCPVGOgZZN{[XluIFXDOVA:OC5yM{Kg{txONg>? NEnIRlQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUm4OVE6PSd-MkW5PFUyQTV:L3G+
human PBMC NFTiTI9Rem:uaX\ldoF1cW:wIHHzd4F6 Ml3IRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCSQl3DMEBKSzVyPUGyJI5O M3\jOFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3Nke5N|A6Lz5zNU[3PVMxQTxxYU6=
mouse T cells MYfGeY5kfGmxbjDhd5NigQ>? NGe2[WM1KGSjeYO= NH75[lBKdW23bn;zeZBxemW|c3n2[UBi[3Srdnn0fUBqdiCvb4Xz[UBVKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[geJdwKHejeTDtbZhm\CCueX3wbI9kgXSnIILlZYN1cW:wIHHmeIVzKDRiZHH5d{BjgSCPVGSgZZN{[XluIHnjOVA:OTFibl2= MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjl6NEm4O{c,OjJ7OES5PFc9N2F-
human splenocytes MW\GeY5kfGmxbjDhd5NigQ>? MX:0JIRigXN? MmH5TY1ufW6xc4XwdJJme3OrdnWgZYN1cX[rdImgbY4hcHWvYX6gd5Bt\W6xY4n0[ZMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBcO0ifdHj5cYllcW6nIHnuZ49zeG:{YYTpc44h[W[2ZYKgOEBl[Xm|IHL5JIFtdG:pZX7pZ{BucXinZDDsfY1xcG:leYTlJJJm[WO2aX;uJIF{e2G7LDDJR|UxRTFyIH7N NUHYV4lIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm4Nlc5OzFpPkG5PFI4QDNzPD;hQi=>
human T-cell NUTWSJF{TnWwY4Tpc44h[XO|YYm= NVPVZWZtUW5idnn0do8hcW6qaXLpeI9zgSCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHQu[2WubDDwdo9lfWO2aX;uJI9nKGy7bYDoc4tqdmViSVytNkwhUUN3ME24MlEhdk1? Mof2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPzV|N{OzNUc,PzV|N{OzNVww[T5?
human Jurkat cells MXLGeY5kfGmxbjDhd5NigQ>? NX7NS4N4OSCq MnfXRY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDpckBpfW2jbjDKeZJs[XRiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBidnSrLVPEN{9ETDJ6IHHueIljd2S7LXnu[JVk\WRiSVytNkBxem:mdXP0bY9vKHS{ZXH0[YQh\m:{IEGgbJIh[mWob4LlJIFvfGlvQ1SzM2NFOjhiYX70bYJw\HliY3jhcIxmdmenIH3lZZN2emWmIHHmeIVzKDZiaILzJIJ6KGmvbYXuc5N2eHC{ZYPzbY9vKGG|c3H5MEBGSzVyPUWgcm0> NHL0UWo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUmzN|c6PSd-MUm5N|M4QTV:L3G+
human PBMC NIjtVJFHfW6ldHnvckBie3OjeR?= MWixJIg> MYfBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJIh2dWGwIGDCUWMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBidnSrLVPEN{9ETDJ6IHHueIljd2S7LXnu[JVk\WRiSVytNkBxem:mdXP0bY9vKHS{ZXH0[YQh\m:{IEGgbJIh[mWob4LlJIFvfGlvQ1SzM2NFOjhiYX70bYJw\HliY3jhcIxmdmenIH3lZZN2emWmIHHmeIVzKDZiaILzJIJ6KGmvbYXuc5N2eHC{ZYPzbY9vKGG|c3H5MEBGSzVyPUOuNUBvVQ>? MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTl|M{e5OUc,OTl7M{O3PVU9N2F-
Jurkat cells M3i0dWZ2dmO2aX;uJIF{e2G7 NXf5eYR{UW2vdX7vd5VxeHKnc4PpeoUh[WO2aY\peJkhf2G|IH3lZZN2emWmIHL5JIlvcGmkaYTpc44hd2ZidHjlJGlNNTJicILv[JVkfGmxbjDpckBLfXKtYYSgZ4VtdHNuIFnDOVA:OiCwTR?= NYnFRWhSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUS2OFM{OzdpPkG0OlQ{OzN5PD;hQi=>
HepG2 cells MUnGeY5kfGmxbjDhd5NigQ>? M{LWPGlvcGmkaYTpc44hd2ZibHn2[ZIhe3SjZ3WgVIxie22xZHn1cUBj\XKpaHXpJIlv\mWldHnvckBqdiCKZYDHNkBk\WyuczygTWM2OD1zLk[1JI5O MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV6NkGyOEc,OjJ3OE[xNlQ9N2F-
Jurkat NVTYfIJDTnWwY4Tpc44h[XO|YYm= MkHGWIhmKGOxbYDveY5lKHejczD0[ZN1\WRiaX6geol1em9iZn;yJIlvcGmkaYTpc44hd2ZiSVytNkBz\WynYYPlJJN1cW23bHH0[YQhf2m2aDDQUWEwcW:wb335Z4lvKGK7IFr1dotifCClZXzsd{4tKEmFNUCgQUAxNjBzMjFOwG0v MkfXQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPzR5M{W0N{c,PzR5M{W0N|ww[T5?
mouse spleen cells NVzWd21pTnWwY4Tpc44h[XO|YYm= MonlWIhmKGOxbYDveY5lKHejczD0[ZN1\WRiaX6geol1em9iZn;yJIlvcGmkaYTpc44hd2ZicILvcIln\XKjdHnvckBqdiCERF[xJI1wfXOnIIPwcIVmdiClZXzsd{B{fGmvdXzheIVlKHerdHigZ49v[2GwYY\hcIlvKEFiKFPvcmEqNixiSVO1NEA:KDBwMESg{txONg>? MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek84PDd|NUSzK|44PDd|NUSzQE9iRg>?
Sf9 NFXoN3BHfW6ldHnvckBie3OjeR?= NFTVfZBqdmirYnn0bY9vKG:oIG\ldoFx[W2rbDDzeIlufWyjdHXkJGFVWCCqeXTyc4x6e2m|IHnuJI1mdWK{YX7ld{Bnem:vIF3EVlEu\XiycnXzd4lv\yCVZkmgZ4VtdHNuIFvpJF0hOC5yMjFOwG0v MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek84PTF2Mk[zK|44PTF2Mk[zQE9iRg>?
LLC-PK1 Ml\VSpVv[3Srb36gZZN{[Xl? MVz0doFve2WyaYTo[Yxq[WxidILhcpNxd3K2IDjiZZNidCC2bzDhdIlk[WxrIHnuJG1FWjFvZYjwdoV{e2mwZzDMUGMuWEtzIHPlcIx{NCCNbTC9JFgvPCEQvF2u Mnj5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwPzZ6MUC1PUc,PzZ6MUC1PVww[T5?
HeLa M2PzSGZ2dmO2aX;uJIF{e2G7 MkTrbY5pcWKrdHnvckBw\iCOVFO0JJVxfGGtZTDpckBu\W2kcnHu[UB3\XOrY3zlJIZzd21iTWLQNU1mgHC{ZYPzbY5oKEinTHGgZ4VtdHNuIFvpJF0hPSEQvF2u NXrGRlVrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxN{m2NVcxPid-N{m2NVcxPjxxYU6=
Caco-2 MV3GeY5kfGmxbjDhd5NigQ>? MXH0doFve2WyaYTo[Yxq[WxidILhcpNxd3K2IDjiZZNidCC2bzDhdIlk[WxrIHnuJGNi[29vMjDj[YxteyxiS32gQUA{NjhizszNMi=> MkG3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwQDh2MkS1Nkc,QDh2MkS1Nlww[T5?
spleen Mo\hSpVv[3Srb36gZZN{[Xl? MXXF[oZm[3Rib3[gZ49ueG:3bnSgc44hUUxvMjDwdo9lfWO2aX;uJIZzd21iYXzsc4FvfGmpZX6td5RqdXWuYYTl[EBud3W|ZTDzdIxm\W5iY3XscJMtKEmFNUCgQUAxNjBzIN88UU4> NVezc3UxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxOEi5N|g{QSd-OEi5N|g{QTxxYU6=
COS Mk\rSpVv[3Srb36gZZN{[Xl? NGS1XFJqdmirYnn0bY9vKG:oIGTheZJw[2ixbHH0[UB2eHSja3WgbY4hSVOEVD3lfJBz\XO|aX7nJGNQWyClZXzsd{whU2liPTCyOEDPxE1w NV[xcVlHRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxOUS1PFc5PSd-OUS1PFc5PTxxYU6=
LLC-PK1 NWLyb5ZWTnWwY4Tpc44h[XO|YYm= NX\YUpk5cW6qaXLpeIlwdiCxZjDEc5hwenWkaXPpckB1emGwc3XwbZRp\WyrYXygeJJidnOyb4L0JEhj[XOjbDD0c{BieGmlYXypJEhFcWexeHnuPkAxNjhidV2pJIlvKE2GUkGt[ZhxemW|c3nu[{BNVENvUFuxJINmdGy|LDDJR|UxKD1iMz62OkDPxE1w NUTNSmFzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxOUmxOFc6Oid-OUmxOFc6OjxxYU6=
CEM/VLB100 M2HrXGZ2dmO2aX;uJIF{e2G7 M{i2UIlvcGmkaYTpc44hd2ZiQ3HsZ4Vqdi2DTTDl[oZtfXhiaX6gR2VON1[OQkGwNEBk\WyuczygT4khRSBzLkig{txONg>? MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yODF7OEKyO{c,OTBzOUiyNlc9N2F-
HEK M2j3W2Z2dmO2aX;uJIF{e2G7 M{nmXYlvcGmkaYTpc44hd2ZiQl3HJJVxfGGtZTDpckBu\W2kcnHu[UB3\XOrY3zld{Bnem:vIF3ydFIu\XiycnXzd4lv\yCKRVugZ4VtdHNuIFvpJF0hOTBizszNMi=> NXXTT2tORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC0NlE3PThpPkGwOFIyPjV6PD;hQi=>
HEK Mn[3SpVv[3Srb36gZZN{[Xl? MV3pcohq[mm2aX;uJI9nKEKPRzD1dJRic2ViaX6gcYVu[nKjbnWgeoV{cWOuZYOg[pJwdSCPUmCyMYV5eHKnc4PpcochUEWNIHPlcIx{NCCNaTC9JFIyKM7:TT6= Mli1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB2MkG2OVgoRjFyNEKxOlU5RC:jPh?=
HeLa NFLmSVdHfW6ldHnvckBie3OjeR?= NHjGWmxqdmirYnn0bY9vKG:oIGTheZJw[2ixbHH0[UB2eHSja3WgbY4hVlSFUD3lfJBz\XO|aX7nJGhmVGFiY3XscJMtKEmFNUCgQUAyKM7:TT6= MnjkQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB3NkW4OFMoRjFyNU[1PFQ{RC:jPh?=
LLC-PK1 MmDFSpVv[3Srb36gZZN{[Xl? MV\pcohq[mm2aX;uJI9nKEyWQ{SgeZB1[WunIHnuJI1mdWK{YX7lJJZme2mlbHXzJIZzd21iTWLQNk1mgHC{ZYPzbY5oKEyOQzDQT|Eh[2WubIOsJGtqKD1iND63JO69VS5? MlroQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTB3N{CwOFkoRjFyNUewNFQ6RC:jPh?=
Sf9 NH;yVZNHfW6ldHnvckBie3OjeR?= NYrxeIRncW6qaXLpeIlwdiCxZjDUZZVzd2Oqb3zheIUhfXC2YXvlJIlvKG2nbXLyZY5mKH[nc3njcIV{KG[{b32gRpNmeC2neIDy[ZN{cW6pIGPmPUBk\WyuczygT4khRSByLkOg{txONg>? NVLzOoJMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC2OFg1PzBpPkGwOlQ5PDdyPD;hQi=>
Caco-2 M1TBcGZ2dmO2aX;uJIF{e2G7 NV7YWXZicW6qaXLpeIlwdiCxZjDEbYdwgGmwIITyZY5{\XCrdHjlcIlidCC2cnHud5BwenRiKHLhd4FtKHSxIHHwbYNidCliKFTp[495cW58IEWgeW0qKGmwIFPhZ48uOiClZXzsd{whUUN3MDC9JFEvOyEQvF2u NWHlcFZKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUC4NlAyOzdpPkGwPFIxOTN5PD;hQi=>
CEM/VLB100 NY\KUnd1TnWwY4Tpc44h[XO|YYm= NXrqS2ZqcW6qaXLpeIlwdiCxZjDDZYxk\WmwLVHNJIVn\my3eDCoR4Ft[2Wrbj3BUVohOC5{NTD1UUkhcW5iQ1XNM3ZNSjFyMDDj[YxteyxiSVO1NEA:KDNwNEGg{txONg>? NEKybHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMEi5NVEyPCd-MUC4PVEyOTR:L3G+
Sf9 NYLl[ZRITnWwY4Tpc44h[XO|YYm= NHX3cHBqdmirYnn0bY9vKG:oIFHUVIF{\SCrbjDt[Y1jemGwZTD2[ZNq[2ynIH\yc40hSkOUUD3lfJBz\XO|aX7nJHNnQSClZXzsd{whU2liPTCwMlUh|ryPLh?= NHzw[4I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUSzO|M5OCd-MUG0N|c{QDB:L3G+
NIH-3T3-G185 MYLGeY5kfGmxbjDhd5NigQ>? NFPQfWZqdmirYnn0bY9vKG:oIFTheY5wenWkaXPpckBm\m[udYigbY4hVkmKLUPUN{1IOTh3IHPlcIx{NCCLQ{WwJF0hOS52IN88UU4> NUnacIluRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG3NVY2OTRpPkGxO|E3PTF2PD;hQi=>
NIH-3T3-G185 NUDMOVlqTnWwY4Tpc44h[XO|YYm= M372eIlvcGmkaYTpc44hd2ZiQ3HsZ4Vqdi2DTTDl[oZtfXhiaX6gUmlJNTOWMz3HNVg2KGOnbHzzMEBKSzVyIE2gNU44KM7:TT6= MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTdzNkWxOEc,OTF5MU[1NVQ9N2F-
NIH-3T3-G185 MnvUSpVv[3Srb36gZZN{[Xl? NV;EU|ZvcW6qaXLpeIlwdiCxZjDSbI9l[W2rbnWgNVI{KGWoZnz1fEBqdiCQSVitN3Q{NUdzOEWgZ4VtdHNuIFnDOVAhRSBzLkeg{txONg>? M4LM[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzN{G2OVE1Lz5zMUexOlUyPDxxYU6=
NIH-3T3-G185 MVHGeY5kfGmxbjDhd5NigQ>? NFnHUGJqdmirYnn0bY9vKG:oIFzEV{04PTFiZX\mcJV5KGmwIF7JTE0{XDNvR{G4OUBk\WyuczygTWM2OCB;IEGuPEDPxE1w MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTdzNkWxOEc,OTF5MU[1NVQ9N2F-
NIH-3T3-G185 MnO0SpVv[3Srb36gZZN{[Xl? NIXSSVJqdmirYnn0bY9vKG:oIGTleJJidWW2aInsdo9{[W2rbnWg[YZndHW6IHnuJG5KUC1|VEOtS|E5PSClZXzsd{whUUN3MDC9JFIvOSEQvF2u MkTYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF5MU[1NVQoRjFzN{G2OVE1RC:jPh?=
NIH-3T3-G185 NH3jdVJHfW6ldHnvckBie3OjeR?= MWLpcohq[mm2aX;uJI9nKE[udX:tN{1CVSCnZn\seZghcW5iTlnIMVNVOy2JMUi1JINmdGy|LDDJR|UxKD1iMj60JO69VS5? MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTdzNkWxOEc,OTF5MU[1NVQ9N2F-
NIH-3T3-G185 NYfrNopuTnWwY4Tpc44h[XO|YYm= M1zFS4lvcGmkaYTpc44hd2ZiSlOtNUBm\m[udYigbY4hVkmKLUPUN{1IOTh3IHPlcIx{NCCLQ{WwJF0hPC5|IN88UU4> MoqyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF5MU[1NVQoRjFzN{G2OVE1RC:jPh?=
HCT15 NXnUT3Q1TnWwY4Tpc44h[XO|YYm= NFnCV3IxNjRidH:gOk4{KHWpL33M NYD3VmRRVW:mdXzheIlwdiCxZjDQMYdxKGmwIHj1cYFvKEiFVEG1JINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKESLTlnCMYlv\HWlZXSgZ5l1d3SxeHnjbZR6KGG2IECuOEB1dyB4LkOgeYcwdUxw NUfjTWFERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG3OVQ3ODJpPkGxO|U1PjB{PD;hQi=>
UO31 NFjERlJHfW6ldHnvckBie3OjeR?= Mn\HNE41KHSxIE[uN{B2\y:vTB?= Mn3wUY9lfWyjdHnvckBw\iCSLXfwJIlvKGi3bXHuJHVQOzFiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gSGlPUUJvaX7keYNm\CCleYTveI95cWOrdImgZZQhOC52IITvJFYvOyC3Zz;tUE4> NX\K[YVTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUG3OVQ3ODJpPkGxO|U1PjB{PD;hQi=>
CAKI1 M4TlW2Z2dmO2aX;uJIF{e2G7 MYiwMlQhfG9iNj6zJJVoN22O MkHjUY9lfWyjdHnvckBw\iCSLXfwJIlvKGi3bXHuJGNCU0lzIHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJGRKVkmELXnu[JVk\WRiY4n0c5RwgGmlaYT5JIF1KDBwNDD0c{A3NjNidXevcWwv MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTd3NE[wNkc,OTF5NUS2NFI9N2F-
MDA-435/LCC6 and MDA-435/LCC6-MDRI M1P0NWZ2dmO2aX;uJIF{e2G7 M33FS2NwdmOnboTyZZRqd25idHjheEBz\WS3Y3XzJJRp\SCmaX\m[ZJmdmOnIHnuJJJmfmW{c3HsJI9nKESRWDDhZ4N2dXWuYYTpc44h[mW2d3XlckBOTEFvNEO1M2xESzZiYX7kJG1FSS12M{WvUGNEPi2PRGLJJINmdGy|IHL5JFUxLS5uIFXDOVAhRSByLkWg{txONg>? MnT6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF5OESxOFMoRjFzN{i0NVQ{RC:jPh?=
MDA-435/LCC6 NVXz[ppvTnWwY4Tpc44h[XO|YYm= NYLRfJR3TW[oZXP0JI9vKHKndnXyd4FtKG:oIGuzTH0uKF[ETDDhZ4N2dXWuYYTpc44hcW5iTVTBMVQ{PS:OQ1O2JEhR\3BvbnXnZZRqfmVrIHPlcIx{NixiRVO1NEA:KDBwNjFOwG0v MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTd6NEG0N{c,OTF5OESxOFM9N2F-
MDA-435/LCC6 and MDA-435/LCC6-MDRI M4TDS2Z2dmO2aX;uJIF{e2G7 NXvDUZByS2:wY3XueJJifGmxbjD0bIF1KHKnZIXj[ZMh\GmoZnXy[Y5k\SCrbjDy[ZZmenOjbDDv[kBcO0ifVlLMJIFk[3WvdXzheIlwdiCkZYT3[YVvKE2GQT20N|UwVEOFNjDhcoQhVUSDLUSzOU9NS0N4LV3EVmkh[2WubIOgZpkhPTBnLDDFR|UxKD1iMD62JO69VS5? NF7HcXE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUe4OFE1Oyd-MUG3PFQyPDN:L3G+
MDA435/LCC6 MDR1 MmrvSpVv[3Srb36gZZN{[Xl? M2juO5JmfmW{c3HsJI9nKF[rbnLsZZN1cW6nIHHjZ5VufWyjdHnvckApXmmwYnzhd5RqdmV8IECuNFA2KHWPKTDpckBOTEF2M{WvUGNEPiCPRGKxJINmdGy|LDDFR|UxKD1iMD62JO69VS5? NFi5R|Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUe4OFE1Oyd-MUG3PFQyPDN:L3G+
MDA-435/LCC6 (Pgp-negative) M3vsRmZ2dmO2aX;uJIF{e2G7 NEXtOHdG\m[nY4Sgc44hemW4ZYLzZYwhd2ZiRF;YJIFk[3WvdXzheIlwdiCrbjDNSGEuPDN3L1zDR|YhMFCpcD3u[YdifGm4ZTmgZ4VtdHNwLDDFR|UxKD1iMD63JO69VS5? NGXIT4k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUe4OFE1Oyd-MUG3PFQyPDN:L3G+
MDA-435/LCC6 M1riVWdzd3e2aDDpcohq[mm2b4L5JIF{e2G7 NYHxdVRlT3Kxd4ToJIlvcGmkaYTvdpkh[WO2aY\peJkhd25iTVTBMVQ{PS:OQ1O2JEhR\3BvcH;zbZRqfmVrIHj1cYFvKGK{ZXHzeEBk[W6lZYKgZ4VtdHNwLDDJR|UxKD1iMTFOwG0v MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOTd6NEG0N{c,OTF5OESxOFM9N2F-
MDA-435/LCC6-MDRI M3yzXmdzd3e2aDDpcohq[mm2b4L5JIF{e2G7 MYnHdo94fGhiaX7obYJqfG:{eTDhZ5Rqfmm2eTDvckBOTEFvNEO1M2xESzZvTVTSTUApWGeyLX7l[4F1cX[nKTDoeY1idiCkcnXhd5Qh[2GwY3XyJINmdGy|LjygTWM2OCB;IEGuNUDPxE1w NIDWU5k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zMUe4OFE1Oyd-MUG3PFQyPDN:L3G+
BTI-TN5B1-4 MoewSpVv[3Srb36gZZN{[Xl? NIi0cIRCXFBiaInkdo9tgXOrczDpckBu\W2kcnHu[UBnemGldHnvckBnem:vIFjp[4ghTmm4ZTCoRnRKNVSQNVKxMVQqKGOnbHzzMEBMdSB;IECuNVch|ryPLh?= M{Xye|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzN{i1Olg1Lz5zMUe4OVY5PDxxYU6=
Jurkat MVLGeY5kfGmxbjDhd5NigQ>? MnO1TY5pcWKrdHnvckBw\iCycn;keYN1cW:wIH;mJGlNNTJic3XjdoV1cW:wIHnuJGp2emujdDDj[YxteyxiSVO1NEA:KDBwMEC3JO69VS5? MkXPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF6OEG5PFQoRjFzOEixPVg1RC:jPh?=
Jurkat M17ocWZ2dmO2aX;uJIF{e2G7 M3\v[2lvcGmkaYTpc44hd2ZicILv[JVkfGmxbjDv[kBj\XSjLXfhcIFkfG:|aXThd4UhUUxvMjDSS2EhcW5iSoXyb4F1KGOnbHzzMEBKSzVyIE2gNE4xODhizszNMi=> MoXRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTF6OEG5PFQoRjFzOEixPVg1RC:jPh?=
LLC-PK1 NHGxV|dHfW6ldHnvckBie3OjeR?= NIfVS5hqdmO{ZXHz[UBqdiCYaX7icIF{fGmwZTDpcpRz[WOnbHz1cIFzKGGlY4XteYxifGmxbjDpckBOTFJzLXX4dJJme3OrbnegUGxENVCNMTDj[YxteyxiS3mgQUAyNjNizszNMi=> M3\jT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzOU[xNVE{Lz5zMUm2NVEyOzxxYU6=
LLC-PK1 M1;3OmZ2dmO2aX;uJIF{e2G7 MWLpcoNz\WG|ZTDpckBE[WylZXnuMWFOKGmwdILhZ4VtdHWuYYKgZYNkfW23bHH0bY9vKGmwIF3EVlEu\XiycnXzd4lv\yCOTFOtVGsyKGOnbHzzMEBMcSB;IESuOlYh|ryPLh?= M2Pw[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFzOU[xNVE{Lz5zMUm2NVEyOzxxYU6=
MDCK MlrjSpVv[3Srb36gZZN{[Xl? NFnOcotqdmirYnn0bY9vKG:oIFTp[495cW5idILhcpNmeGm2aHXsbYFtKHS{YX7zdI9zfCBqYnHzZYwhfG9iYYDpZ4FtMSCrbjDNSHIyNWW6cILld5NqdmdiTVTDT{Bk\WyuczygT4khRSB{LkG4JO69VS5? MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOjF|NEm0OUc,OTJzM{S5OFU9N2F-
MDCK NV\MNpBpTnWwY4Tpc44h[XO|YYm= M3\mfolvcGmkaYTpc44hd2ZiVnnuZoxie3SrbnWgeJJidnOncHn0bIVtcWGuIITyZY5{eG:{dDCoZoF{[WxidH:gZZBq[2GuKTDpckBOWlB{LXX4dJJme3OrbnegUWREUyClZXzsd{whU2liPTC4MlEyKM7:TT6= Mk\DQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTJzM{S5OFYoRjF{MUO0PVQ3RC:jPh?=
LLC-PK1 NU\sUVNGTnWwY4Tpc44h[XO|YYm= Ml7WbY5kemWjc3WgbY4hS2GuY3Xpck1CVSCrboTyZYNmdGy3bHHyJIFk[3WvdXzheIlwdiCrbjDt[JIy[i2neIDy[ZN{cW6pIFzMR{1RUzFiY3XscJMtKEurIE2gN{42KM7:TT6= M2jF[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF{MkO1NlY4Lz5zMkKzOVI3PzxxYU6=
LLC-PK1 MVfGeY5kfGmxbjDhd5NigQ>? NV3VbI44cW6lcnXhd4UhcW5iQ3HsZ4Vqdi2DTTDpcpRz[WOnbHz1cIFzKGGlY4XteYxifGmxbjDpckBu\HJzYT3lfJBz\XO|aX7nJGxNSy2SS{GgZ4VtdHNuIFvpJF0hOy54NTFOwG0v NY\aNHlZRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUKyN|UzPjdpPkGyNlM2OjZ5PD;hQi=>
HL-60 NIjCfYZHfW6ldHnvckBie3OjeR?= MWfJcohq[mm2b4L5JIFkfGm4aYT5JIFo[Wmwc4SgTJVu[W5iZn;ycZlteGWydHnk[UBz\WOncITvdkApTlCUKTDv[kBpfW2jbjDs[ZVs\W2rYTDIUE03OCClZXzsd{whUUN{MDC9JFMvPiEQvF2u Ml;uQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTJ|NkGzPFgoRjF{M{[xN|g5RC:jPh?=
High Five cells NIj0bIxHfW6ldHnvckBie3OjeR?= Ml:2bY5pcWKrdHnvckBw\iCWYYXyc4Np\W6xZHXvfJlkcG:uYYTlJJVxfGGtZTjDd2EhOzC3TTygN|AhLSCxZjDjc451em:uKTDpckBu\W2kcnHu[UB3\XOrY3zld{BxemWyYYLl[EBnem:vIFjp[4ghTmm4ZTDj[YxteyCrbn\lZ5Rm\CC5aYToJJRp\SCDQlPCNVEh[mGldXzveolzfXNuIFvpJF0hQS53IN88UU4> M2\BV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF{NEC0NlM6Lz5zMkSwOFI{QTxxYU6=
MDCKII MULGeY5kfGmxbjDhd5NigQ>? NFTiWoRqdmirYnn0bY9vKG:oIFPldol3[XO2YYTpckB2eHSja3WgbY4hV0GWUEKt[ZhxemW|c3nu[{BOTEONSVmgZ4VtdHNuIFvpJF0hOC5{M{ig{txONg>? Mn61QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTJ3M{i4NVMoRjF{NUO4PFE{RC:jPh?=
Caco-2 MkTHSpVv[3Srb36gZZN{[Xl? MlfOeJJidnOncHn0bIVtcWGuIITyZY5{eG:{dDDv[kBlcWexeHnuJEhj[XOjbDD0c{BieGmlYXypJIlvKEOjY3:tNkBk\WyuczygT4khRSByLkO1JO69VS5? NVr2TII2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUK2N|YyPTNpPkGyOlM3OTV|PD;hQi=>
SK-E2 NXnWSmdVTnWwY4Tpc44h[XO|YYm= NELGU45qdmO{ZXHz[UBqdiCkb3TpdJkhcW62cnHj[YxtfWyjcjDhZ4N2dXWuYYTpc44hMEKxZHnwfVohOC5{IIXNLUBqdiCVSz3FNkBk\WyuczCo[ZhxemW|c3nu[{BDW0WSKTygTWM2OCB;IEeuOUDPxE1w M{DTO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF{N{O5O|U6Lz5zMkezPVc2QTxxYU6=
SK-E2 M2XG[mZ2dmO2aX;uJIF{e2G7 MVzpcoNz\WG|ZTDpckBlcWi7ZILv[ox2d3Knc3PlbY4hcW62cnHj[YxtfWyjcjDhZ4N2dXWuYYTpc44hMGSraInkdo9ndHWxcnXzZ4VqdjpiMTD1UUkhcW5iU1utSVIh[2WubIOgLIV5eHKnc4PpcochSlOHUDmsJGlEPTBiPTC3Mlgh|ryPLh?= M1ex[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF{N{O5O|U6Lz5zMkezPVc2QTxxYU6=
HEK293 MnniSpVv[3Srb36gZZN{[Xl? Ml;obY5pcWKrdHnvckBw\iCSaHHscI9q\GmwIIXweIFs\SBqUHjhcIxwcWSrbkqgNUB2VSliaX6gU2FVWC2FLXX4dJJme3OrbnegTGVMOjl|IHPlcIx{NCCNaTC9JFAvOiEQvF2u M3fSWFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF2NUOwPVA4Lz5zNEWzNFkxPzxxYU6=
T-cells MYXGeY5kfGmxbjDhd5NigQ>? MV\Jcohq[mm2aX;uJI9nKGGubH;n[Y5q[yClZXzsd{1{fGmvdXzheIVlKHC{b3zp[oVz[XSrb36gbY4hdW:3c3WgWEBk\WyuczDifUBucXinZDDsfY1xcG:leYTlJJJm[WO2aX;uJI1mfGixZDygTWM2OCB;IECuNFMzKM7:TT6= NGCz[pk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zNEW5N|E5Oid-MUS1PVMyQDJ:L3G+
T-cells MXzGeY5kfGmxbjDhd5NigQ>? MnjzTY5pcWKrdHnvckBw\iCjbHzv[4VvcWNiY3XscJMue3SrbYXsZZRm\CCycn;sbYZmemG2aX;uJIlvKGi3bXHuJHQh[2WubIOgZpkhdWm6ZXSgcJlueGixY4n0[UBz\WGldHnvckBu\XSqb3SsJGlEPTBiPTCwMlA4PCEQvF2u MYW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPDV7M{G4Nkc,OTR3OUOxPFI9N2F-
PMBC NYfSbod5TnWwY4Tpc44h[XO|YYm= NYP0UmlpPzJiaILz NXjWZ2JlTW[oZXP0JI9vKHC{b3zp[oVz[XSrb36gc4YhcHWvYX6gdIVzcXCqZYLhcEBjdG:xZDDtc45wdnWlbHXhdkBk\WyuczCoVG1DSyliYYSgO|IhcHJidYPpcochVVSWIHHzd4F6NCCLQ{WwJF0hQC57NzFOwG0v M{HFPFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF3MkCzNVY{Lz5zNUKwN|E3OzxxYU6=
mouse spleen cells MU\DfZRwfG:6aXPpeJkh[XO|YYm= NYe1U|Z7S3m2b4TvfIlkcXS7IHHnZYlve3RiQlHMRk9kKG2xdYPlJJNxdGWnbjDj[YxteyxiQ1O1NEA:KDFwM{Wg{txONg>? M2Lse|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MEixO|YyLz5zN{C4NVc3OTxxYU6=
MDCK2 NHLp[lFHfW6ldHnvckBie3OjeR?= M{X2S2lvcGmkaYTpc44hd2ZiaIXtZY4hVUSUMT3k[ZBmdmSnboSgZYNkfW23bHH0bY9vKG:oIHPhcINmcW5vQV2g[ZhxemW|c3XkJIlvKE2GQ1uyJINmdGy|LDDJR|UxKD1iOT6zOEDPxE1w M3\UflxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5Nk[0N|I4Lz5zN{[2OFMzPzxxYU6=
HEK293 NUjqWJBzTnWwY4Tpc44h[XO|YYm= NWHLSo5oUW6qaXLpeIlwdiCxZjDjdo9{ey2uaX7rbY5oKG:oIHj1cYFvKFCpcDDUUVEhVDZ3Uj;UUVYhVDN|OVOvWG04KEZ5MkigcZV1[W62IHX4dJJme3OnZDDpckBJTUt{OUOgZ4VtdHNiYYPz[ZN{\WRiYYOg[JJ2\yCuZY\lcEBk[XW|aX7nJFUxLSCrbnjpZol1cW:wIH;mJINzd3O|IHzpcotqdmdiYomgbY1ufW6xYnzveEwhSWO2aY\peJkhRSByLkWg{txONg>? NYHnRVlERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe4OFg2PjNpPkG3PFQ5PTZ|PD;hQi=>
HEK293 MVfGeY5kfGmxbjDhd5NigQ>? Ml7RTY5pcWKrdHnvckBw\iClcn;zd{1tcW6taX7nJI9nKGi3bXHuJHBoeCCWTU[gUFM{QUNxVF23JGY4OjiFIH31eIFvfCCneIDy[ZN{\WRiaX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IHTyeYchdGW4ZXygZ4F2e2mwZzC1NEUhcW6qaXLpeIlwdiCxZjDjdo9{eyCuaX7rbY5oKGK7IHntcZVvd2Kub4SsJGFkfGm4aYT5JF0hOC54IN88UU4> MW[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzh2OEW2N{c,OTd6NEi1OlM9N2F-
HEK293 M{DqOmZ2dmO2aX;uJIF{e2G7 NWXVOnlHUW6qaXLpeIlwdiCxZjDjdo9{ey2uaX7rbY5oKG:oIHj1cYFvKFCpcDDUUVNVOTl7Uj;UUVYhVDN|OVOvWG04KEZ5MkjDJI12fGGwdDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHzd4V{e2WmIHHzJIRzfWdibHX2[Ywh[2G3c3nu[{A2OCViaX7obYJqfGmxbjDv[kBkem:|czDsbY5scW6pIHL5JIludXWwb3Lsc5QtKEGldHn2bZR6KD1iMT6xJO69VS5? MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzh2OEW2N{c,OTd6NEi1OlM9N2F-
HEK293 MU\GeY5kfGmxbjDhd5NigQ>? MnntTY5pcWKrdHnvckBw\iClcn;zd{1tcW6taX7nJI9nKGi3bXHuJHBoeCCWTU[gSlM1O1JxVF22JGw{OzmFL2TNO{BHPzJ6QzDteZRidnRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDkdpVoKGyndnXsJINifXOrbnegOVAmKGmwaHnibZRqd25ib3[gZ5Jwe3NibHnub4lv\yCkeTDpcY12dm:kbH;0MEBC[3Srdnn0fUA:KDFzIN88UU4> NWj3VHdvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe4OFg2PjNpPkG3PFQ5PTZ|PD;hQi=>
HEK293 NFLibm5HfW6ldHnvckBie3OjeR?= MkntTY5pcWKrdHnvckBw\iClcn;zd{1tcW6taX7nJI9nKGi3bXHuJHBoeCCWTUWgTVMxPlJxVF22JGw{OzmFL2TNO{BHPzJ6QzDteZRidnRiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDkdpVoKGyndnXsJINifXOrbnegOVAmKGmwaHnibZRqd25ib3[gZ5Jwe3NibHnub4lv\yCkeTDpcY12dm:kbH;0MEBC[3Srdnn0fUA:KDF3IN88UU4> MknnQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd6NEi1OlMoRjF5OES4OVY{RC:jPh?=
MDCK2 MkTESpVv[3Srb36gZZN{[Xl? MX2xNEB2VQ>? MmfKOFAhdWmwcx?= NGXaT25KdmirYnn0bY9vKG:oIHj1cYFvKHerbHSgeJlx\SCSZ4Cg[ZhxemW|c3XkJIlvKE2GQ1uyJINmdGy|IHHzd4V{e2WmIHHzJINidGOnaX6tRW0h[WOldX31cIF1cW:wIHH0JFExKHWPIHHmeIVzKDRyIH3pcpMv NX\uUWpVRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe5OlQyPzBpPkG3PVY1OTdyPD;hQi=>
A2780 M175eGZ2dmO2aX;uJIF{e2G7 NIrxfXo{OCCvaX7z M3n2R2lvcGmkaYTpc44hd2ZiaIXtZY4hWGeyIHnuJGEzPzhyIHPlcIx{KGGodHXyJFMxKG2rboOgZpkhUG:nY3jzeEA{OzN2MjDhd5NigSxiSVO1NEA:KDFwNEGyOVQh|ryPLh?= MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDB6M{CzOEc,OThyOEOwN|Q9N2F-
A2780 NHHSZ5lHfW6ldHnvckBie3OjeR?= MVKzNEBucW6| M1SwS2lvcGmkaYTpc44hd2ZiaIXtZY4hWGeyIHnuJGEzPzhyIHPlcIx{KGGodHXyJFMxKG2rboOgZpkh[2GuY3XpckBCVSCjc4PhfUwhUUN3MDC9JFEvPDF{NUSg{txONg>? MmTlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOThyOEOwN|QoRjF6MEizNFM1RC:jPh?=
Caco-2 NVvadFRwTnWwY4Tpc44h[XO|YYm= MWTJcohq[mm2aX;uJI9nKFBvZ3z5Z49xem:2ZXnuMY1m\GmjdHXkJHs{UF24aX7icIF{fGmwZTD0doFve3CxcoSgbY4hcHWvYX6gR4Fkdy1{IHPlcIx{NCCHQ{WwJF0hPDVwNTFOwG0v NFj0e209[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEWyOFU6Oid-MUi1NlQ2QTJ:L3G+
A2780 MWPGeY5kfGmxbjDhd5NigQ>? NYG1NGd1UW6qaXLpeIlwdiCxZjDQMYdxKGmwIHj1cYFvKGGmcnnhcZlkcW5vcnXzbZN1[W62IFGyO|gxKGOnbHzzJIJ6KEixZXPod5QhOzN|NEKgZZN{[XluIFnDOVAhRSBzLkSxNlU1KM7:TT6= MlG4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTh4N{i0PVUoRjF6Nke4OFk2RC:jPh?=
Huh-9-13 MlTKRY51cX[rcnHsJIF{e2G7 NUHwXm9tOyCmYYnz NI\lN3pCdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBDUUyQIEKwOlEuemW|aYP0ZY51KEiFVjDn[Y5wfHmyZTCxZkBqdm[nY4Tl[EBqdiCqdX3hckBJfWhvOT2xN{Bk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5idnnyZYwhemWybHnjZZRqd25iYX\0[ZIhOyCmYYnzJIJ6KHG3YX70bZRifGm4ZTDSWE1RS1JuIFXDOVAhRSByLkCwOEDPxE1w MYK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTFyNECxN{c,OTlzMESwNVM9N2F-
Huh-9-13 M4O5eGFvfGm4aYLhcEBie3OjeR?= NWPJU|BHOyCmYYnz MYDBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDjc41xd3WwZD3y[ZNqe3SjboSgTGNXKGenbn;0fZBmKDGkIHnu[oVkfGWmIHnuJIh2dWGwIFj1bE06NTF|IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckB3cXKjbDDy[ZBtcWOjdHnvckBi\nSncjCzJIRigXNiYomgdZVidnSrdHH0bZZmKFKWLWDDVkwhTUN3MDC9JFAvOzVizszNMi=> MonxQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTlzMESwNVMoRjF7MUC0NFE{RC:jPh?=
Huh-9-13 M4\WdWFvfGm4aYLhcEBie3OjeR?= MnHqN{Bl[Xm| MVHBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDCyK{1ENW2ndHj5cE0zLy2obIXvdo8u[3m2aXTpcoUuemW|aYP0ZY51KEiFVjDn[Y5wfHmyZTCxZkBqdm[nY4Tl[EBqdiCqdX3hckBJfWhvOT2xN{Bk\WyuczDhd5Nme3OnZDDhd{Bz\WS3Y4Tpc44hcW5idnnyZYwhemWybHnjZZRqd25iYX\0[ZIhOyCmYYnzJIJ6KHG3YX70bZRifGm4ZTDSWE1RS1JuIFXDOVAhRSByLkSg{txONg>? M3:0TVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7MUC0NFE{Lz5zOUGwOFAyOzxxYU6=
Huh-9-13 MVzBcpRqfmm{YXygZZN{[Xl? M3XXXVMh\GG7cx?= M3XRW2FvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JHZZKDl3MD3y[ZNqe3SjboSgTGNXKGenbn;0fZBmKDGkIHnu[oVkfGWmIHnuJIh2dWGwIFj1bE06NTF|IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckB3cXKjbDDy[ZBtcWOjdHnvckBi\nSncjCzJIRigXNiYomgdZVidnSrdHH0bZZmKFKWLWDDVkwhTUN3MDC9JFAvPDlizszNMi=> MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTFyNECxN{c,OTlzMESwNVM9N2F-
Huh-9-13 MmXrRY51cX[rcnHsJIF{e2G7 MVezJIRigXN? NYPHVlBCSW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhWjR5OT3y[ZNqe3SjboSgTGNXKGenbn;0fZBmKDGkIHnu[oVkfGWmIHnuJIh2dWGwIFj1bE06NTF|IHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckB3cXKjbDDy[ZBtcWOjdHnvckBi\nSncjCzJIRigXNiYomgdZVidnSrdHH0bZZmKFKWLWDDVkwhTUN3MDC9JFEvQThizszNMi=> NGnUUWs9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUGwOFAyOyd-MUmxNFQxOTN:L3G+
Huh-9-13 NWXFOZpxSW62aY\pdoFtKGG|c3H5 MoPXN{Bl[Xm| NITpSZFCdnSrdnnyZYwh[WO2aY\peJkh[WejaX7zeEBkgWOub4Pwc5JqdmVvcnXzbZN1[W62IFjDWkBo\W6xdInw[UAy[iCrbn\lZ5Rm\CCrbjDoeY1idiCKdXitPU0yOyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6geolz[WxicnXwcIlk[XSrb36gZYZ1\XJiMzDkZZl{KGK7IIH1ZY51cXSjdHn2[UBTXC2SQ2KsJGVEPTBiPTCzMlg2KM7:TT6= NVzqcWNyRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUmxNFQxOTNpPkG5NVA1ODF|PD;hQi=>
A2780/ADR M4HSUmZ2dmO2aX;uJIF{e2G7 NFHM[nBKdmirYnn0bY9vKG:oIGCt[4x6[2:ycn;0[YlvNW2nZHnheIVlKG23bITp[JJ2\yC{ZYPpd5RidmOnIHnuJIFlemmjbYnjbY4uemW|aYP0ZY51KGi3bXHuJGEzPzhyL1HEVkBk\WyuczDifUBk[WylZXnuJGFOKGG|c3H5MEBKSzVyIE2gNU41KM7:TT6= NFPDTms9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUK1NFg{PCd-MUmyOVA5OzR:L3G+
C2C12 MkPaSpVv[3Srb36gZZN{[Xl? MXmwMlEhfWdxbXy= MWWzJIRigXN? Mmm2TY5pcWKrdHnvckBw\iCqZYjvd4UuPi2yaH;zdIhifGViZHXofYRzd2enbnHz[U1qdmS3Y3XkJINmdGxiZHnm[oVz\W62aXH0bY9vKGmwIH3veZNmKEN{Q{GyJINmdGy|IHHzd4V{e2WmIHHzJI16d3OrbjDo[YF3gSClaHHpckBndHWxcnXzZ4Vv[2ViYYSgNE4yKHWpL33sJIZweiB|IHThfZMv M2XwWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMEixPFU2Lz5{MEC4NVg2PTxxYU6=
C2C12 NWXuW|hLTnWwY4Tpc44h[XO|YYm= MX\Jcohq[mm2aX;uJI9nKHOncoXtJJdqfGimcnH3ZYwucW6mdXPl[EBk\WyuIHTp[oZmemWwdHnheIlwdiCrbjDtc5V{\SCFMlOxNkBk\WyuczDhd5Nme3OnZDDhd{BugW:|aX6gbIVifnliY3jhbY4h\XiycnXzd4lwdi5? NHnGdmI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEC4NVg2PSd-MkCwPFE5PTV:L3G+
HuH7 M1\pOGFvfGm4aYLhcEBie3OjeR?= NGnvT3o1QCCqcoO= NXnK[mY3SW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhUEOYIIP1ZpR6eGViMXKgR49vOSCrbn\lZ5Rm\CCrbjDoeY1idiCKdVi3JINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiC4aYLhcEBTVkFibHX2[Ywh[W[2ZYKgOFghcHK|IHL5JG1VWyCjc4PhfUwhTUN3MDC9JFAvOjFizszNMi=> Mn35QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzN{[4PVQoRjJyMUe2PFk1RC:jPh?=
HuH7 M2fU[GFvfGm4aYLhcEBie3OjeR?= NULw[XM2PDhiaILz M1zrUmFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JIN6[2yxc4Dvdolv\SCDLYLld4l{fGGwdDDIR3Yhe3WkdInw[UAy[iCFb36xJIlv\mWldHXkJIlvKGi3bXHuJGh2UDdiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJJZqemGuIGLORUBt\X[nbDDh[pRmeiB2ODDodpMh[nliTWTTJIF{e2G7LDDFR|UxKD1iMz6zPUDPxE1w MoXhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzN{[4PVQoRjJyMUe2PFk1RC:jPh?=
T-cells NIfzNGhKdW23bn;zeZBxemW|c3n2[UBie3OjeR?= M3jGXlczKGi{cx?= NXT4U4ViUW2vdX7vd5VxeHKnc4PpeoUh[WO2aY\peJkhcW5iQlHMRk9kKG2xdYPlJHQh[2WubIOgZZN{\XO|ZXSgZZMhcW6qaXLpeIlwdiCxZjDhcpRqNUOGMz;hcpRqNUOGMkitd5RqdXWuYYTl[EBk\WyuIIDyc4xq\mW{YYTpc44h[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhUUN3MDC9JFAvODZizszNMi=> M2fTVFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzMUOxNVA1Lz5{MUGzNVExPDxxYU6=
T-cells MkfvR5l1d3SxeHnjbZR6KGG|c3H5 M2LUT|Q5KGi{cx?= NHv6ZZJEgXSxdH;4bYNqfHliYXfhbY5{fCCEQVzCM4MhdW:3c3WgWEBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDDR|UxKD1iMUWuPFIh|ryPLh?= NFHRSGo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUGzNVExPCd-MkGxN|EyODR:L3G+
HCT15 MYrGeY5kfGmxbjDhd5NigQ>? NFXJdYwyOCC3TR?= MnvLTY5pcWKrdHnvckBw\iCPRGKxJIlvKGi3bXHuJGhEXDF3IHPlcIx{KGG|c3Xzd4VlKGG|IHPhcINmcW5vQV2g[YZndHW6IHH0JFExKHWPIHL5JIZtfW:{ZYPj[Y5k\SCjc4PhfU4> MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTN2OES2NUc,OjF|NEi0OlE9N2F-
T-cells NHfFWY5KdW23bn;zeZBxemW|c3n2[UBie3OjeR?= MmTQPVYhcHK| NXq3VJdoUW2vdX7vd5VxeHKnc4PpeoUh[WO2aY\peJkhcW5iQlHMRk9kN0N3N1LMM|YhdW:3c3WgWEBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHHscI9idnSrZ3XuMYlv\HWlZXSgZ4VtdCCycn;sbYZmemG2aX;uJIFnfGW{IEm2JIhzeyCkeTDt[YF{fXKrbnegX|NJZXSqeX3p[Ilv\SC3cIThb4Uh[nlibXn4[YQhdHmvcHjvZ5l1\SC{ZXHjeIlwdiCjc4PhfUwhUUN3MDC9JFAvODF2IN88UU4> NFvwRWI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS1OlUzPCd-MkG0OVY2OjR:L3G+
mouse spleen cells MXPGeY5kfGmxbjDhd5NigQ>? M1[3[mlvcGmkaYTpc44hd2Zic3XybY5mKHCjbH3peI96dHS{YX7z[oVz[XOnIHnuJI1wfXOnIIPwcIVmdiClZXzsd{4> NI\UZ3Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS1OlUzPCd-MkG0OVY2OjR:L3G+
HCT116 NFLGeHBHfW6ldHnvckBie3OjeR?= NEjNZosyOCC3TR?= NWHieXJqOzBibXnudy=> NV;3R21nVW:mdXzheIlwdiCxZjDCR3JRKGmwIHj1cYFvKEiFVEGxOkBk\WyuczDhd5Nme3OnZDDhd{BqdnS{YXPlcIx2dGG{IHHjZ5VufWyjdHnvckBw\iCvaYTvfIFvfHKxbnWgZZQhOTBidV2gZYZ1\XJiM{CgcYlveyCkeTDmcI94NWO7dH;t[ZRzgS5? MmK2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2OEi2PFYoRjJzNEi4Olg3RC:jPh?=
Sf21 NUfxdJBPTnWwY4Tpc44h[XO|YYm= NUTBfXJ2UW6qaXLpeIlwdiCxZjDoeY1idiCEU1XQJIV5eHKnc4Pl[EBqdiCybHHzcYEhdWWvYoLhcoUhfmW|aXPs[ZMhd2ZiU3[yNUBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFHUVE1l\XCnbnTlcpQhYzOKXYTheZJw[2ixbHH0[UB2eHSja3WsJGlEPTBiPTCwMlUh|ryPLh?= NGjaUmo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUm2OVYzOyd-MkG5OlU3OjN:L3G+
Sf21 NYPBOJJSTnWwY4Tpc44h[XO|YYm= M2H2cmlvcGmkaYTpc44hd2ZiU4DyZYd2\S2GYYfs[ZkhemG2IFLz[ZAh\XiycnXzd4VlKGmwIIDsZZNu[SCvZX3idoFv\SC4ZYPpZ4xmeyCxZjDT[lIyKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gRXRRNWSncHXu[IVvfCCdM1jdeIF2em:laH;sZZRmKHWydHHr[UwhUUN3MDC9JFAvPiEQvF2u NUKwZpR[RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG5OlU3OjNpPkKxPVY2PjJ|PD;hQi=>
T-cells NFfWWo9HfW6ldHnvckBie3OjeR?= NHnXd2hKdmirYnn0bY9vKG:oIFPEOEBmgHC{ZYPzbY9vKGmwIHj1cYFvKEOGNDugWEBk\WyuczygTWM2OCB;IEiuPVch|ryPLh?= MmTzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJzMEGxN|UoRjJ{MUCxNVM2RC:jPh?=
L929 NGXFbGlEgXSxdH;4bYNqfHliYYPzZZk> NXH4SGtkPzJiaILz M33FSGN6fG:2b4jpZ4l1gSCjZ3HpcpN1KG2xdYPlJGw6OjliY3XscJMh[W[2ZYKgO|IhcHK|LDDJR|UxKD1iM{OuPUDPxE1w NIPhR|k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkOyNFQxOid-MkKzNlA1ODJ:L3G+
CCRF-CEM/VCR1000 NELWPGlHfW6ldHnvckBie3OjeR?= MVKyOFAhe2Wlcx?= NWj0V2dZUW6qaXLpeIlwdiCxZjDQMYdtgWOxcILveIVqdi2vZXTpZZRm\CCmYYXuc5J2[mmlaX6g[YZndHW6IH\yc40hcHWvYX6gR2NTTi2FRV2vWmNTOTByMDDj[YxteyCjZoTldkAzPDBic3Xjd{BjgSCIQVPTJIZtd3diY4n0c41mfHKrYzDhcoFtgXOrczygTWM2OCB;IECuNVAzOzNizszNMi=> NVvlTIlDRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0OVI1OTJpPkKyOFUzPDF{PD;hQi=>
mouse lymph node cells NFew[5BKdW23bn;zeZBxemW|c3n2[UBie3OjeR?= M3O0eVczKGi{cx?= NX\hVFk5UW2vdX7vd5VxeHKnc4PpeoUh[WO2aY\peJkhcW5iYX70bU1ETDNxYX70bU1ETDhiY3:td5RqdXWuYYTl[EBD[WykL3OgcY92e2VibIntdIghdm:mZTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOnbHygdJJwdGmoZYLheIlwdiCjZoTldkA4OiCqcoOgZpkhTUyLU1GsJGlEPTBiPTCwMlA4KM7:TT6= MkT6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2OUS2NVYoRjJ{NEm0OlE3RC:jPh?=
mouse lymph node cells MUTDfZRwfG:6aXPpeJkh[XO|YYm= MljVOFghcHK| NEW0THFEgXSxdH;4bYNqfHliYXfhbY5{fCCEYXziM4MhdW:3c3WgcJlueGhibn;k[UBk\WyuczDh[pRmeiB2ODDodpMh[nliTWTUJIF{e2G7LDDDR|UxKD1iMUCuNUDPxE1w MlT0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2OUS2NVYoRjJ{NEm0OlE3RC:jPh?=
HEK293 NXXRVpR2TnWwY4Tpc44h[XO|YYm= NULrV4tLPSCvaX7z NY\FNHd3UW6qaXLpeIlwdiCxZjDoeY1idiCuaY\ldkBQSVSSMVKzJIV5eHKnc4Pl[EBqdiCKRVuyPVMhTmyyLVnuJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCdM1jdSVE4NWKndHHHJJVxfGGtZTDpcoN2[mG2ZXSg[o9zKDVibXnud{BjgSC|Y3nueIltdGG2aX;uJINwfW62aX7nMEBMcSB;IEGuNkDPxE1w Mnz6QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ3NEGwOlgoRjJ{NUSxNFY5RC:jPh?=
HEK293 NE\xTnhHfW6ldHnvckBie3OjeR?= MUjJcohq[mm2aX;uJI9nKGi3bXHuJIxqfmW{IF;BWHAySjFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDGcJAuUW5iY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJGUyPy2kZYThS{B2eHSja3WgZpkhe2OrboTpcIxifGmxbjDjc5VvfGmwZzygT4khRSBzLkOg{txONg>? MYG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV2MUC2PEc,OjJ3NEGwOlg9N2F-
HEK293 NFfLdIhHfW6ldHnvckBie3OjeR?= NHKxUZc2KG2rboO= MmPTTY5pcWKrdHnvckBw\iCqdX3hckBtcX[ncjDPRXRROUJ|IHX4dJJme3OnZDDpckBJTUt{OUOgSoxxNUmwIHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBcO0ifRUG3MYJmfGGJIIXweIFs\SCrbnP1ZoF1\WRiZn;yJFUhdWmwczDifUB{[2mwdHnscIF1cW:wIHPveY51cW6pLDDJR|UxKD1iMT6zJO69VS5? M4W2UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NUSxNFY5Lz5{MkW0NVA3QDxxYU6=
HEK293 M{W4b2Z2dmO2aX;uJIF{e2G7 M2nBdGlvcGmkaYTpc44hd2ZiaIXtZY4hdGm4ZYKgU2FVWDGEMTDlfJBz\XO|ZXSgbY4hUEWNMkmzJGZteC2LbjDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hTTF5LXLleIFIKHWydHHr[UBjgSC|Y3nueIltdGG2aX;uJINwfW62aX7nMEBKSzVyIE2gNU41KM7:TT6= MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjV2MUC2PEc,OjJ3NEGwOlg9N2F-
HEK293 NVLicG94TnWwY4Tpc44h[XO|YYm= Ml\pOUBucW6| NILrfWtKdmirYnn0bY9vKG:oIHj1cYFvKGyrdnXyJG9CXFB{QkGg[ZhxemW|c3XkJIlvKEiHS{K5N{BHdHBvSX6gZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKFt|SG3FN3MhfXC2YXvlJIlv[3WkYYTl[EBnd3JiNTDtbY5{KGK7IIPjbY51cWyuYYTpc44h[2:3boTpcoctKEurIE2gN|Yh|ryPLh?= NHT4V5Y9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkW0NVA3QCd-MkK1OFExPjh:L3G+
HEK293 MUXGeY5kfGmxbjDhd5NigQ>? MXG1JI1qdnN? M4DhOWlvcGmkaYTpc44hd2ZiaIXtZY4hdGm4ZYKgU2FVWDKEMTDlfJBz\XO|ZXSgbY4hUEWNMkmzJGZteC2LbjDj[YxteyCjc4Pld5Nm\CCjczDy[YR2[3Srb36gbY4hYzOKXVWzV{B2eHSja3WgbY5kfWKjdHXkJIZweiB3IH3pcpMh[nlic3PpcpRqdGyjdHnvckBkd3WwdHnu[{whUUN3MDC9JFM4KM7:TT6= NU\oR4NpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK1OFExPjhpPkKyOVQyODZ6PD;hQi=>
T-cells MljsTY1ufW6xc4XwdJJme3OrdnWgZZN{[Xl? MmP2NlQhcHK| NFPidYxKdW23bn;zeZBxemW|c3n2[UBi[3Srdnn0fUBqdiCEQVzCM4MhdW:3c3WgWEBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFPvcmEucW6mdXPl[EBVKGOnbHygdJJwdGmoZYLheIlwdiCrbnP1ZoF1\WRiMkSgbJJ{KHCxc4SgR49vSS2rbnT1Z5Rqd25iZn;yJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAzNjF{IN88UU4> MUi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjd{N{O2PUc,OjJ5MkezOlk9N2F-
2008 M3HqcGZ2dmO2aX;uJIF{e2G7 M4j1PVExKHWP MoH1N|AhdWmwcx?= NX;QfVZwUW6qaXLpeIlwdiCxZjDoeY1idiCPUmCxJIV5eHKnc4Pl[EBqdiB{MEC4JINmdGy|IHH0JFExKHWPIIDy[Ylv[3WkYYTl[EBnd3JiM{CgcYlveyCycnnvdkB1dyClYXzj[YlvKEGPIHHk[Il1cW:wIH3lZZN2emWmIHX2[ZJ6KDZyIIPlZ5MhfXBidH:gPVAhdWmwczDifUBk[WylZXnuJGFOKGGlY4XteYxifGmxbjDhd5NigS5? M{HZZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|MEG3PFg5Lz5{M{CxO|g5QDxxYU6=
A2780adr M3nVbGZ2dmO2aX;uJIF{e2G7 M1jvXlExKHWP Ml;zN|AhdWmwcx?= NFzmW21KdmirYnn0bY9vKG:oIHj1cYFvKFBvZ4Cgc5ZmemW6cILld5Nm\CCrbjDkc5hwenWkaXPpckBz\XOrc4ThcpQhSTJ5OEDh[JIh[2WubIOgZZQhOTBidV2gdJJmcW6ldXLheIVlKG[xcjCzNEBucW6|IIDybY9zKHSxIHPhcINmcW5iQV2gZYRlcXSrb36gcYVie3W{ZXSg[ZZmenliNkCgd4VkeyC3cDD0c{A6OCCvaX7zJIJ6KGOjbHPlbY4hSU1iYXPjeY12dGG2aX;uJIF{e2G7Lh?= Ml7qQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjNyMUe4PFgoRjJ|MEG3PFg5RC:jPh?=
HL60 MUHGeY5kfGmxbjDhd5NigQ>? NGriR3Q2KHWP NX3XTotPPDBibXnudy=> MVnJcohq[mm2aX;uJI9nKEOjMjutbY5lfWOnZDDtbZRw[2ixbnTybYFtKHCncn3lZYJqdGm2eTD0doFve2m2aX;uJIlvKGi3bXHuJGhNPjBiY3XscJMh[XRiNTD1UUBi\nSncjC0NEBucW6|IILlcIF1cX[nIITvJINwdnS{b3yu MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzB{NkC4N{c,OjNyMk[wPFM9N2F-
RPMI1788 MYfJcY12dm:|dYDwdoV{e2m4ZTDhd5NigQ>? NVvZToNrPiCmYYnz NIfwcIVKdW23bn;zeZBxemW|c3n2[UBi[3Srdnn0fUBqdiCqdX3hckBTWE2LMUe4PEBk\WyuczDjc4N2dHS3cnXkJJdqfGhiaIXtZY4hWEKPQzDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIGuzTH11cHmvaXTpcoUhcW6lb4Lwc5JifGmxbjDpcoN2[mG2ZXSg[o9zKDZiZHH5d{BxemmxcjD0c{BcO0ifdHj5cYllcW6nIHHk[Il1cW:wIH3lZZN2emWmIHHmeIVzKDF6IHjyd{BjgSCuaYH1bYQhe2OrboTpcIxifGmxbjDjc5VvfGmwZzygTWM2OCB;IECuNFU1KM7:TT6= NInqU2U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{O0O|gxPCd-MkOzOFc5ODR:L3G+
MT4 NEPXXIpCdnSrdnnyZYwh[XO|YYm= NUnQPGlFPCCmYYnz NXj4TG1QSW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhUEmYMTCzRkBqdm[nY4Tl[EBqdiCqdX3hckBOXDRiY3XscJMh[2:rbn\lZ5Rm\CC5aYToJGhVVFZzIHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiC4aYL1d{1qdmS3Y3XkJIN6fG:yYYToc4dmdmmlaYT5JIFnfGW{IESg[IF6eyCkeTDNWHQh[XO|YYmsJGVEPTBiPTCwMlQ2KM7:TT6= NGT4V2g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{i0PVg5OCd-MkO4OFk5QDB:L3G+
A2780Adr M4Poc2Z2dmO2aX;uJIF{e2G7 MmTjN|AhdWmwcx?= M3PncGlvcGmkaYTpc44hd2ZicD3ncJlkd3C{b4TlbY4hMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iaIXtZY4hSTJ5OEDB[JIh[2WubIOgZZN{\XO|ZXSgZZMh[2GuY3Xpck1CVSCjY3P1cZVt[XSrb36gdJJmcW6ldXLheIVlKG[xcjCzNEBucW6|IHLl[o9z\SClYXzj[YlvNUGPIHHk[Il1cW:wIH3lZZN2emWmIIXwJJRwKDlyIH3pcpMh[nliZnz1c5Jme2OnbnPlJIF{e2G7LDDJR|UxKD1iMD65PUDPxE1w M{PDUVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|OEWxNVE1Lz5{M{i1NVEyPDxxYU6=
2008 NFXWOXBHfW6ldHnvckBie3OjeR?= MkToN|AhdWmwcx?= NGD3Zm5KdmirYnn0bY9vKG:oIF3SVFEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iaIXtZY4hOjByODDj[YxteyCjc4Pld5Nm\CCjczDjZYxk\WmwLVHNJIFk[3WvdXzheIlwdiCycnXpcoN2[mG2ZXSg[o9zKDNyIH3pcpMh[mWob4LlJINidGOnaX6tRW0h[WSmaYTpc44hdWWjc4Xy[YQhfXBidH:gPVAhdWmwczDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAzNjhzIN88UU4> NVe4dXVCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO4OVEyOTRpPkKzPFUyOTF2PD;hQi=>
Jurkat T NWfCcY1xTnWwY4Tpc44h[XO|YYm= M{SzSlMxKG2rboO= Mon5TY5pcWKrdHnvckBw\iCQRlHUJIFkfGm4YYTpc44hcW5iUF3BM4lwdm:veXPpck1{fGmvdXzheIVlKGi3bXHuJGp2emujdDDUJINmdGy|IHnuZ5Vj[XSnZDDmc5IhOzBibXnud{BxemmxcjD0c{BRVUFxaX;uc416[2mwIIP0bY12dGG2aX;uJI1m[XO3cnXkJIFnfGW{IEWgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhUUN3MDC9JFAvODBzNDFOwG0v NFXCR3I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{m2OFk6OSd-MkO5OlQ6QTF:L3G+
MDA435/LCC6MDR NXmwSZd4TnWwY4Tpc44h[XO|YYm= MnrnUY9lfWyjdHnvckBw\iCyLXfwJEh2dmuwb4fuJI9zcWerbjmgeJJidnOoZXP0[YQhcW5iaIXtZY4hVUSDNEO1M2xESz[PRGKgZ4VtdHNiYYPz[ZN{\WRiYYOgdoV3\XK|YXygc4YheGGlbHn0ZZhmdCC{ZYPpd5RidmOnLDDFR|UxKD1iMD6wN|Ih|ryPLh?= NYrveWFYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkSxO|E1PzhpPkK0NVcyPDd6PD;hQi=>
MDA435/LCC6 NHr3TnhEgXSxdH;4bYNqfHliYYPzZZk> MnfDN{Bl[Xm| NWfx[GZnS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUSDNEO1M2xESzZiY3XscJMh[XO|ZYPz[YQh[XNiZ4Lve5RpKGmwaHnibZRqd25iYX\0[ZIhOyCmYYnzJIJ6KE2WUzDhd5NigSxiSVO1NEA:KDJwODFOwG0v MnrtQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzN{G0O|goRjJ2MUexOFc5RC:jPh?=
MDA435/LCC6MDR M17rXGN6fG:2b4jpZ4l1gSCjc4PhfS=> NHzZO5A{KGSjeYO= NWX6cIpXS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hVUSDNEO1M2xESz[PRGKgZ4VtdHNiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36gZYZ1\XJiMzDkZZl{KGK7IF3UV{Bie3OjeTygTWM2OCB;IEiuN{DPxE1w MmDzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjRzN{G0O|goRjJ2MUexOFc5RC:jPh?=
L929 M33LV2N6fG:2b4jpZ4l1gSCjc4PhfS=> Mo\SN{Bl[Xm| NVf0ZWZwS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVDl{OTDj[YxteyCjc4Pld5Nm\CCjczDndo94fGhiaX7obYJqfGmxbjDh[pRmeiB|IHThfZMh[nliTWTTJIF{e2G7LDDJR|UxKD1iM{OuPUDPxE1w NHnpUGU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG3NVQ4QCd-MkSxO|E1Pzh:L3G+
A2780adr MlPpSpVv[3Srb36gZZN{[Xl? NFHsZoV2eCC2bzC5NEBucW6| MWjJcohq[mm2aX;uJI9nKE2GUkGgbY4hcHWvYX6g[I95d3K3YnnjbY4uemW|aYP0ZY51KEF{N{iwZYRzKGOnbHzzJIF{e2W|c3XkJIF{KEOjbHPlbY4hSU1iYXPjeY12dGG2aX;uJJRz\WG2ZXSgN|AhdWmwczDi[YZwemViQ3HsZ4VqdiCDTTDh[IRqfGmxbjDt[YF{fXKnZDD1dEB1dyB7MDDtbY5{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IECuPVIh|ryPLh?= NF3yfmY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEG4OFIyOyd-MkSxPFQzOTN:L3G+
2008 MUPGeY5kfGmxbjDhd5NigQ>? MV\1dEB1dyB7MDDtbY5{ NUfaV3FmUW6qaXLpeIlwdiCxZjDNVnAyKGmwIHj1cYFvKDJyMEigZ4VtdHNiYYPz[ZN{\WRiYYOgR4Ft[2WrbjDBUUBi[2O3bYXsZZRqd25idILlZZRm\CB|MDDtbY5{KGKnZn;y[UBE[WylZXnuJGFOKGGmZHn0bY9vKG2nYYP1doVlKHWyIITvJFkxKG2rboOgZpkh\my3b4Lld4NmdmOnIHHzd4F6NCCLQ{WwJF0hOi55IN88UU4> MVK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDF6NEKxN{c,OjRzOESyNVM9N2F-
Saos2 MY\GeY5kfGmxbjDhd5NigQ>? Mk\FOUB2VQ>? MX2zJIhzew>? NXHzfIVnUW6qaXLpeIlwdiCxZjDwMYdxKGmwIHTvfI9zfWKrY3nuMZJme2m|dHHueEBpfW2jbjDTZY9{OiClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDkc5hwenWkaXPpckB2eHSja3WgZZQhPSC3TTDh[pRmeiB|IHjyd{BjgSCobH;3JIN6fG:vZYTybYMh[W6jbInzbZMv Ml;ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR5MkC0OVIoRjJ2N{KwOFUzRC:jPh?=
Saos2 MVjGeY5kfGmxbjDhd5NigQ>? NV7pVJdGPSC3TR?= NYrpV|NIOiCqcoO= MV\Jcohq[mm2aX;uJI9nKHBvZ4CgbY4h\G:6b4L1ZolkcW5vcnXzbZN1[W62IHj1cYFvKFOjb4OyJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGmwdILhZ4VtdHWuYYKg[I95d3K3YnnjbY4hemW2ZX70bY9vKGG2IEWgeW0h[W[2ZYKgNkBpenNiYomg[oxwfyCleYTvcYV1emmlIHHuZYx6e2m|Lh?= NXvOb2JJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS3NlA1PTJpPkK0O|IxPDV{PD;hQi=>
Saos2 M2H6SmZ2dmO2aX;uJIF{e2G7 MVW1JJVO M3\IUFIhfG9iMzDodpM> MmfETY5pcWKrdHnvckBw\iCyLXfwJIlvKGSxeH;yeYJq[2mwLYLld4l{fGGwdDDoeY1idiCVYX;zNkBk\WyuczDhd5Nme3OnZDDhd{BqdnS{YXPlcIx2dGG{IHTvfI9zfWKrY3nuJIRqe3S{aXL1eIlwdiCrbjDueYNt\WliYYSgOUB2VSCjZoTldkAzKHSxIEOgbJJ{KGK7IHzhd4VzKHOlYX7ubY5oKGOxbn\vZ4FtKG2rY4Lvd4NweGmlIHHuZYx6e2m|Lh?= M365SlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2N{KwOFUzLz5{NEeyNFQ2OjxxYU6=
mouse NULPOIRuTnWwY4Tpc44h[XO|YYm= Mne2TY5pcWKrdHnvckBw\iCqdX3hckBOTFJzIHX4dJJme3OnZDDpckBud3W|ZTDMOVE4QCClZXzsd{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDpcpRz[WOnbHz1cIFzKGGlY4XteYxifGmxbjDv[kBzcG:mYX3pcoUhOTJ|IHL5JGZCS1OFYXzpZpVzKG[ub4egZ5l1d22ndIL5MEBKSzVyIE2gNE43PyEQvF2u NXH2ZlY6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFAzOjZpPkK0PVAxOjJ4PD;hQi=>
A2780 MYPGeY5kfGmxbjDhd5NigQ>? MmnIOUB2VQ>? NEjSNZU1OCCvaX7z MXzJcohq[mm2aX;uJI9nKFCpcD3t[YRq[XSnZDDkdpVoKGWoZnz1fEBqdiCjZILpZY16[2mwLYLld4l{fGGwdDDoeY1idiCDMke4NEBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCrboTyZYNmdGy3bHHyJIFlemmjbYnjbY4hdGW4ZXygZZQhPSC3TTDh[pRmeiB2MDDtbY5{KGK7IH\sc5ch[3m2b33leJJ6KGGwYXz5d4l{Ng>? NUXWOWt5RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkS5NFA{OjNpPkK0PVAxOzJ|PD;hQi=>
A2780 NXHHNXo2TnWwY4Tpc44h[XO|YYm= NFfYRoE2KHWP NYHpbnVFOSCqch?= MWDJcohq[mm2aX;uJI9nKFCpcD3t[YRq[XSnZDDkdpVoKGWoZnz1fEBqdiCjZILpZY16[2mwLYLld4l{fGGwdDDoeY1idiCDMke4NEBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCjZILpZY16[2mwIIXweIFs\SCjdDC1JJVOKGGodHXyJFEhcHJiYomg[oxwfyCleYTvcYV1enliYX7hcJl{cXNw NHn3bFI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFMzOyd-MkS5NFA{OjN:L3G+
A2780 Mn\4SpVv[3Srb36gZZN{[Xl? Mo\uOUB2VQ>? M{XGWlghcHK| NWLsSWhqUW6qaXLpeIlwdiCxZjDQ[5AudWWmaXH0[YQh\HK3ZzDl[oZtfXhiaX6gZYRzcWGveXPpck1z\XOrc4ThcpQhcHWvYX6gRVI4QDBiY3XscJMh[XO|ZYPz[YQh[XNiaX7jdoVie2ViaX6gZYRzcWGveXPpckB2eHSja3WgZZQhPSC3TTDh[pRmeiB6IHjyd{BjgSCobH;3JIN6fG:vZYTyfUBidmGueYPpd{4> MlLhQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjR7MECzNlMoRjJ2OUCwN|I{RC:jPh?=
T-cells NXrCbFl1SW62aXnu[oxidW2jdH;yfUBie3OjeR?= M{\TO|AvODFidH:gNVAxKG6P M37KUFIh\GG7cx?= MUHBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJGxNVzFzODDUR3IhfHKjboPn[Y5q[yCvb4Xz[UBKVC1{LXPvcZBmfGWwdDDDSFQueG:|aYTpeoUhXCClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJGxNVyBqMUmwJJRwKDJyNTmtbY5lfWOnZDDJUE0zKHC{b3T1Z5Rqd25iYYSgNE4xOSC2bzCxNFAhdk1iZn;yJFIh\GG7czDifUBndG:5IHP5eI9u\XS{aXOgZY5idHm|aYOu MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPDlyMEi2Okc,OjR7MEC4OlY9N2F-
Th17 NULleHRSSW62aXnu[oxidW2jdH;yfUBie3OjeR?= NXnjUnhDOTBidH:gNVAxKG6P NGPT[HIzKGSjeYO= MUDBcpRqcW6obHHtcYF1d3K7IHHjeIl3cXS7IHnuJGxNVzFzODDUR3IhfHKjboPn[Y5q[yCvb4Xz[UBVcDF5IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhUUxvMUegdJJw\HWldHnvckBifCBzMDD0c{AyODBibl2g[o9zKDJiZHH5d{BjgSCobH;3JIN6fG:vZYTybYMh[W6jbInzbZMv M2LzeVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwPFY3Lz5{NEmwNFg3PjxxYU6=
Th1 Mn;FRY51cWmwZnzhcY1ifG:{eTDhd5NigQ>? NHnRd2QyODBibl2= NIP4XWgzKGSjeYO= MnvIRY51cWmwZnzhcY1ifG:{eTDhZ5Rqfmm2eTDpckBNVE9zMUigWGNTKHS{YX7z[4VvcWNibX;1d4UhXGhzIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhUU[QLXfhcY1iKHC{b3T1Z5Rqd25iYYSgNVAxKG6PIH\vdkAzKGSjeYOgZpkh\myxdzDjfZRwdWW2cnnjJIFv[Wy7c3nzMi=> M{L4WFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUCwPFY3Lz5{NEmwNFg3PjxxYU6=
NCI/ADR-RES NUDET3Y5TnWwY4Tpc44h[XO|YYm= M1nIRlIxKG2rboO= MlG4TY5pcWKrdHnvckBw\iCqdX3hckBRNWeueXPvdJJwfGWrbjDlfJBz\XO|ZXSgbY4hVkOLL1HEVk1TTVNiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIH;mJINidGOnaX6tRW0hfHKjboPwc5J1KGGodHXyJFIxKG2rboOgZpkh\my3b4Lld4NmdmOnIHHzd4F6Ng>? M1\URVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ2OUmyNVU{Lz5{NEm5NlE2OzxxYU6=
A2780adr MlHRSpVv[3Srb36gZZN{[Xl? MnzHPVAhdWmwcx?= NWDYcmt6UW6qaXLpeIlwdiCxZjDBRmNDOSCrbjDoeY1idiCDMke4NIFleiClZXzsd{BxemVvaX7jeYJifGWmIH\vdkA{OCCvaX7zJIZwdGyxd3XkJIJ6KGOjbHPlbY4hSU1iYXTkbZRqd25iYX7kJIZ2enSqZYKgbY5kfWKjdHXkJIZweiB4MDDtbY5{KGK7IHPhcINmcW5iQV2gZZN{[XluIFnDOVAhRSByLkmxPUDPxE1w MonMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6NUW4PVUoRjJ3OEW1PFk2RC:jPh?=
T spleen cells NUe2bmxUS3m2b4TvfIlkcXS7IHHzd4F6 NHnDXmI4OiCqcoO= Mo\hR5l1d3SxeHnjbZR6KGGpYXnud5QhUUOUIH3veZNmKFRic4Ds[YVvKGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gZ4VtdCCycn;sbYZmemG2aX;uJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGlEPTBiPTCwMlAyKM7:TT6= M1u0TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NU[0NlY3Lz5{NkW2OFI3PjxxYU6=
B spleen cells NHvrSHJEgXSxdH;4bYNqfHliYYPzZZk> NGHFdW84OiCqcoO= NWiybYNXS3m2b4TvfIlkcXS7IHHnZYlve3RiSVPSJI1wfXOnIFKgd5Bt\WWwIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDwdo9tcW[ncnH0bY9vKGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEmFNUCgQUAxNjB2IN88UU4> MoDZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ3NkSyOlYoRjJ4NU[0NlY3RC:jPh?=
RD NVvlV3dsSW62aY\pdoFtKGG|c3H5 M3XxflI1KGi{cx?= MYTBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDFWlcyKGmwZnXjeIVlKGmwIGLEJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIHHzd4F6NCCHQ{WwJF0hOy54NjFOwG0v M{fyT|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4NU[0NlY3Lz5{NkW2OFI3PjxxYU6=
mouse lymph node cells MUjGeY5kfGmxbjDhd5NigQ>? MoLyTY5pcWKrdHnvckBw\iCSSUPLMYdidW2jIHnuJI1wfXOnIHz5cZBpKG6xZHWgZ4VtdHNiYYPz[ZN{\WRiYYOgbY5pcWKrdHnvckBw\iCFb37BMZN1cW23bHH0[YQhXCClZXzsJJBzd2yrZnXyZZRqd25uIFnDOVAhRSByLkW3JO69VS5? Ml:2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZ5MkCxOVQoRjJ4N{KwNVU1RC:jPh?=
CD1 MmnNSpVv[3Srb36gZZN{[Xl? NEfmdZMxNjFidH:gNVAhfU1? MluxN|AhdWmwcx?= MWPJcohq[mm2aX;uJI9nKHSjdYLvcIl1cG:laH;sZZRmKGGlaXSgN{1{fWyoYYTlMYlv\HWlZXSgcoVkem:|aYOgbY4hS0RzIH3veZNmKHCjbnPy[YF1cWNiYXPpcoFzKGOnbHzzJIF1KDBwMTD0c{AyOCC3TTDh[pRmeiB|MDDtbY5{KGK7IIDyc5Bq\Gm3bTDpc4Rq\GVic4ThbY5qdmdiYnHz[YQh[2:wZn;jZYwhdWmlcn;zZ49xcWNiYX7hcJl{cXNw MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjl3MEO5Nkc,OjZ7NUCzPVI9N2F-
A2780/ADR NXTjb492TnWwY4Tpc44h[XO|YYm= MmDCN|AhdWmwcx?= MYjJcohq[mm2aX;uJI9nKEGEQ1KxJIlvKGi3bXHuJGEzPzhyL1HEVkBk\WyuczDpcoN2[mG2ZXSg[o9zKDNyIH3pcpMhdWWjc4Xy[YQhfXBidH:gN|YxOCC|ZXPzJJdqfGhidHnt[UBqdnSnco\hcJMhd2ZiNkCgd4VkeyCkeTDjZYxk\WmwIHHjZ5VufWyjdHnvckBie3OjeTygTWM2OCB;IEGuOFEh|ryPLh?= NGCwTlM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{GwNFA{Oyd-MkexNFAxOzN:L3G+
A2780/ADR NVnUdmN2S3m2b4TvfIlkcXS7IHHzd4F6 M1PIblczKGi{cx?= M4HQeWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGEzPzhyL1HEVkBk\WyuczDveoVz\XiycnXzd4lv\yCDQlPCNUBie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhPzJiaILzJIJ6KE2WVDDhd5NigSxiR1m1NEA:KDhwNkOg{txONg>? M3TKV|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5MUCwNFM{Lz5{N{GwNFA{OzxxYU6=
A2780 M{PXW2N6fG:2b4jpZ4l1gSCjc4PhfS=> Ml\5O|IhcHK| NVGxR2JsS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hSTJ5OECgZ4VtdHNiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKGOnbHygeoli[mmuaYT5JIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGdKPTBiPTC4Mlk1KM7:TT6= MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzFyMECzN{c,OjdzMECwN|M9N2F-
MDCK2 M4e5ZWZ2dmO2aX;uJIF{e2G7 MmrsTY5pcWKrdHnvckBw\iCDQlPDNkApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCPRFPLNkBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHPhcINmcW5vQV2g[YZndHW6IH3lZZN2emWmIHHmeIVzKDNyIH3pcpMhcW5icILld4Vv[2Vib3[gRWJESjFiaX7obYJqfG:{IFfGNVIxQTF6IHHu[EBCSkOFMTDpcohq[mm2b4KgUWsuPTdzIHL5JIZtd3diY4n0c41mfHK7LDDJR|UxKD1iMkWuOkDPxE1w MmTGQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd|OUO5OFkoRjJ5M{mzPVQ6RC:jPh?=
Flp-InTM-293 NF36TWNHfW6ldHnvckBie3OjeR?= M2nibFI2KHWP MmLlN|AhdWmwcx?= NEPrdGJKdmirYnn0bY9vKG:oIFHCR2MzKCi3bnvuc5dvKG:{aXfpckkh\XiycnXzd4VlKGmwIHj1cYFvKE[ucD3JcnRONTJ7MzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOjbHPlbY4uSU1iZX\mcJV5KGG2IEK1JJVOKG2nYYP1doVlKGGodHXyJFMxKG2rboOgbY4heHKnc3XuZ4Uhd2ZiQVLDRlEhcW6qaXLpeI9zKEeIMUKwPVE5KGGwZDDBRmNEOSCrbnjpZol1d3JiTVutOVcyKGK7IH\sc5ch[3m2b33leJJ6Ng>? MV28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzN7M{m0PUc,Ojd|OUO5OFk9N2F-
hamster BHK21 MmfaSpVv[3Srb36gZZN{[Xl? NFeyR5IzPSC3TR?= M4S4eVMxKG2rboO= MljTTY5pcWKrdHnvckBw\iCqdX3hckBCSkOFMTDlfJBz\XO|ZXSgbY4hcGGvc4TldkBDUEt{MTDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKGOjbHPlbY4uSU1iZX\mcJV5KGG2IEK1JJVOKG2nYYP1doVlKGGodHXyJFMxKG2rboOgZpkh\myxdzDjfZRwdWW2comu MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzN7M{m0PUc,Ojd|OUO5OFk9N2F-
MDCK2 MXLGeY5kfGmxbjDhd5NigQ>? NUXGbnhyOjVidV2= M4foOlMxKG2rboO= MXPJcohq[mm2aX;uJI9nKEGEQ1OyJEh2dmuwb4fuJI9zcWerbjmg[ZhxemW|c3XkJIlvKE2GQ1uyJINmdGy|IHHzd4V{e2WmIHHzJIlvcGmkaYTpc44hd2ZiY3HsZ4Vqdi2DTTDl[oZtfXhiYYSgNlUhfU1ibXXhd5Vz\WRiYX\0[ZIhOzBibXnud{BqdiCycnXz[Y5k\SCxZjDBRmNDOSCrbnjpZol1d3JiR1[xNlA6OThiYX7kJGFDS0NzIHnubIljcXSxcjDNT{02PzFiYomg[oxwfyCleYTvcYV1enlw NEXicGc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{O5N|k1QSd-MkezPVM6PDl:L3G+
NH3T3 MkHlSpVv[3Srb36gZZN{[Xl? NGPjWHozNjVidV2= Ml3PN|AhdWmwcx?= MoHlTY5pcWKrdHnvckBw\iCqdX3hckBCSkOEMTDlfJBz\XO|ZXSgbY4hdW:3c3WgUmg{XDNiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBk[WylZXnuMWFOKGWoZnz1fEBifCB{LkWgeW0hdWWjc4Xy[YQh[W[2ZYKgN|AhdWmwczDifUBndG:5IHP5eI9u\XS{eT6= M3HwUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5M{mzPVQ6Lz5{N{O5N|k1QTxxYU6=
Jurkat T M{TKdWludXWwb4P1dJBz\XO|aY\lJIF{e2G7 MUOxN{BpenN? MWLJcY12dm:|dYDwdoV{e2m4ZTDhZ5Rqfmm2eTDpckBpfW2jbjDQUWEwcW:wb335Z4lvKHO2aX31cIF1\WRiSoXyb4F1KFRiY3XscJMh[XO|ZYPz[YQh[XNic4XwdJJme3Orb36gc4YhUUx{IIDyc4R2[3Srb36gdJJmfHKnYYTl[EB4cXSqIHPlcIx{KG[xbHzve4VlKGK7IGDNRU9qd26xbYnjbY4he3SrbYXsZZRqd25ibXXhd5Vz\WRiYX\0[ZIhOTNiaILzJIJ6KEWOSWPBMEBKSzVyIE2gNE4xOTFizszNMi=> M3nXcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5NkS3N|cxLz5{N{[0O|M4ODxxYU6=
A2780/ADR MmLjSpVv[3Srb36gZZN{[Xl? Mnz5N|AhdWmwcx?= NV7qfVBnUW6qaXLpeIlwdiCxZjDBRmNDOSCrbjDoeY1idiCDMke4NE9CTFJiY3XscJMh[XO|ZYPz[YQh[XNicnXkeYN1cW:wIHnuJINidGOrZX6tRW0h\W[obIX4JJBz\WmwY4XiZZRm\CCob4KgN|AhdWmwczDmc4xtd3enZDDifUBk[WylaXXuMWFOKGGmZHn0bY9vKG2nYYP1doVlKGmvbXXkbYF1\Wy7IHH0JFYxKHOnYzD0bY1mKGmwdHXyeoFtKG[xcjC2NEBucW6|IHL5JIZtfW:{ZYPj[Y5k\SCjc4PhfUwhUUN3MDC9JFEvOjFizszNMi=> NIHPUJA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{[3OlQ3QSd-Mke2O|Y1Pjl:L3G+
MDA435/LCC6MDR M3TkeGZ2dmO2aX;uJIF{e2G7 M2jHSVEhfU1? MlvhOUBl[Xm| NW\TfXd2UW6qaXLpeIlwdiCxZjDQMYdxKGmwIHj1cYFvKE2GQUSzOU9NS0N4TVTSJINmdGy|IHHzd4V{e2WmIHHzJJBwfGWwdHnheIlwdiCxZjDwZYNtcXSjeHXsMYlv\HWlZXSgZ5l1d3SxeHnjbZR6KGK7IH3lZZN2emmwZzDwZYNtcXSjeHXsJGlEPTBiYYSgNUB2VSCvZXHzeZJm\CCjZoTldkA2KGSjeYOgZpkhS2WubDDUbZRmeiB7NjDBdZVmd3W|IHHzd4F6KCiUdnKgQUAyOzlwMzCrM{0hPy53IH7NLUwhUUN3MDC9JFAvODBzODFOwG0v NX32S5ZpRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMke3OVAyQTdpPkK3O|UxOTl5PD;hQi=>
K562R NXyybZFiTnWwY4Tpc44h[XO|YYm= NFvSXFU2KHWP NH7vS48yKGi{ NXP5eohUUW6qaXLpeIlwdiCxZjDQMYdxKGmwIHTvfI9zfWKrY3nuMZJme2m|dHHueEBpfW2jbjDLOVYzWiClZXzsd{Bie3Onc4Pl[EBieyC{aH;kZY1qdmViZX\mcJV5KGK7IH3lZZN2emmwZzDyZZRqdyCxZjDt[YFvKG[udX;y[ZNk\W6lZTDpcpRmdnOrdImgbY4heHKnc3XuZ4Uh[W6mIHHid4Vv[2Vib3[gZ49ueG:3bnSgZZQhPSC3TTDpcoN2[mG2ZXSg[o9zKDFiaIKgZpkh\myxdzDjfZRwdWW2comu MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPzd3M{S4NEc,Ojd5NUO0PFA9N2F-
HuH7 MYnBcpRqfmm{YXygZZN{[Xl? M3flWVczKGi{cx?= MWXBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDIR3Yh\2Wwb4T5dIUhOWJiQ3;uNUBqdm[nY4Tl[EBqdiCqdX3hckBJfUh5IHPlcIx{KGGodHXyJFczKGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkG3JO69VS5? MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDB5NUW5NUc,OjhyN{W1PVE9N2F-
HepaRG NFrkVWJCdnSrdnnyZYwh[XO|YYm= MkPMNVYhcHK| NX3Y[oQ4SW62aY\pdoFtKGGldHn2bZR6KGGpYXnud5QhUEKYIHnu[oVkfGWmIHnuJIh2dWGwIFjldIFTTyClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6geolz[WxiaX7m[YN1cW:wIHHmeIVzKDF4IHjyd{whUUN3MDC9JFAvOiEQvF2u M3LnZlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6M{izNlc1Lz5{OEO4N|I4PDxxYU6=
replicon 2A cells NEXqe21HfW6ldHnvckBie3OjeR?= MV23NkBpenN? NGLDeoVKdmirYnn0bY9vKG:oIH3UU3Ihe2mpbnHsbY5oKHCjdHj3ZZkhcW5iKIXub45wf25ib4Lp[4lvMSCrbjDzeYIu\2Wwb33pZ{Bz\XCuaXPvckAzSSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gdIhwe3Cqb4L5cIF1\WRicoDzOkBxem:2ZXnuJIxmfmWuczD1dEB1dyB2MECgcm0h[W[2ZYKgO|IhcHK|IHL5JHdme3Sncn6gZoxwfCCjbnHsfZNqey5? M1TnWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6NESyNlU3Lz5{OES0NlI2PjxxYU6=
A2780adr M4fzPGZ2dmO2aX;uJIF{e2G7 M{DKTlMxKG2rboO= NEi4SodKdmirYnn0bY9vKG:oIFHCR2IyKGmwIHj1cYFvKEF{N{iwZYRzKGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDjZYxk\WmwIFHNJIxmfmWuczDwdoVqdmO3YnH0[YQh\m:{IEOwJI1qdnNiZn;scI94\WRiYomgZ4Ft[2WrbjDBUUBi\GSrdHnvckBu\WG|dYLl[EBqdW2nZHnheIVtgSCjdDC2NEB{\WNidHnt[UBqdnSnco\hcEBnd3JiNkCgcYlveyCkeTDmcJVwemW|Y3XuZ4Uh[XO|YYmsJGlEPTBiPTCxMlIyKM7:TT6= Mk\1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2N{G2OVYoRjJ6NEexOlU3RC:jPh?=
H69AR MX7GeY5kfGmxbjDhd5NigQ>? NGPBbnQ{OCCvaX7z MWrJcohq[mm2aX;uJI9nKEGEQ1OxJIlvKGi3bXHuJGg3QUGUIHPlcIx{KGG|c3Xzd4VlKGG|IILl[JVkfGmxbjDpckBk[WylZXnuJGFOKGyndnXsd{BxemWrbnP1ZoF1\WRiZn;yJFMxKG2rboOg[o9tdG:5ZXSgZpkh[2GuY3XpckBCVSCjZHTpeIlwdiCvZXHzeZJm\CCrbX3l[IlifGWueTDheEA3OCC|ZXOgeIlu\SCrboTldpZidCCob4KgOlAhdWmwczDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAzNjl5IN88UU4> MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQDR5MU[1Okc,Ojh2N{G2OVY9N2F-
A2780/ADR MoTLSpVv[3Srb36gZZN{[Xl? M4e2VVMxKG2rboO= NHPzfJZKdmirYnn0bY9vKG:oIFHCR2IyKGmwIHj1cYFvKEF{N{iwM2FFWiClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4Ft[2Wrbj3BUUBm\m[udYigdJJmcW6ldXLheIVlKG[xcjCzNEBucW6|IH\vcIxwf2WmIHL5JINidGOnaX6tRW0h[WSmaYTpc44hdWWjc4Xy[YQh[XRiNkCgd4VkeyCrboTldpZidCCob4KgOlAhdWmwczDifUBndHWxcnXzZ4Vv[2ViYYPzZZktKEmFNUCgQUAyNjJzIN88UU4> NF;IUlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEi0NVUyOyd-Mki4OFE2OTN:L3G+
H69AR NXO2emZkTnWwY4Tpc44h[XO|YYm= M4D3[lMxKG2rboO= NGLxZXhKdmirYnn0bY9vKG:oIFHCR2MyKGmwIHj1cYFvKEh4OVHSJINmdGy|IHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiClYXzj[YlvNUGPIHXm[ox2gCCycnXpcoN2[mG2ZXSg[o9zKDNyIH3pcpMh\m:ubH;3[YQh[nliY3HsZ4Vqdi2DTTDh[IRqfGmxbjDt[YF{fXKnZDDheEA3OCC|ZXPzJIlvfGW{dnHsJIZweiB4MDDtbY5{KGK7IH\seY9z\XOlZX7j[UBie3OjeTygTWM2OCB;IEOuOVMh|ryPLh?= NHHaV|g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OEi0NVUyOyd-Mki4OFE2OTN:L3G+
A673 MknjdWhVWyCjc4PhfS=> NEXPfVVyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiQU[3N{Bk\Wyucz6= MoHBQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
Saos-2 MV;xTHRUKGG|c3H5 MkP6dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKFOjb4OtNkBk\Wyucz6= NUPL[2R1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
BT-37 NHrFXWJyUFSVIHHzd4F6 MXzxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhSlRvM{egZ4VtdHNw M1v5clxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
RD M2K0[JFJXFNiYYPzZZk> NInNTIhyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiUlSgZ4VtdHNw M2HHXFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
MG 63 (6-TG R) M1;YV5FJXFNiYYPzZZk> MojvdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE2JIE[zJEg3NVSJIGKpJINmdGy|Lh?= NXfZPIJYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
NB1643 NX;ROFIyeUiWUzDhd5NigQ>? MoDZdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6EMU[0N{Bk\Wyucz6= M1LTTFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
OHS-50 NVrYT4o4eUiWUzDhd5NigQ>? NGf3eFNyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiT1jTMVUxKGOnbHzzMi=> NVPN[3ZnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh41 NEX6b|NyUFSVIHHzd4F6 MYfxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhWmh2MTDj[Yxtey5? NWjlSnh1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh30 MmTHdWhVWyCjc4PhfS=> M{PzeZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHJpOzBiY3XscJMv MUe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Rh41 Ml34dWhVWyCjc4PhfS=> NWrue|l3eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhWmh2MTDj[Yxtey5? NILwW4s9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC NEf5fmpyUFSVIHHzd4F6 M17aWJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCVSz3OMW1EKGOnbHzzMi=> NUOzTGlLRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Rh18 M1ywcZFJXFNiYYPzZZk> M{LSbZFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KFC{aX3hdpkhe2O{ZXXuJIZweiCUaEG4JINmdGy|Lh?= NH7BZ3A9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
SK-N-MC MlvKdWhVWyCjc4PhfS=> MlOwdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohS2:wZnnycYF1d3K7IIPjdoVmdiCob4KgV2suVi2PQzDj[Yxtey5? M1PD[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
TC32 NHjaWIlyUFSVIHHzd4F6 M3fGbJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHREOzJiY3XscJMv M{eyVVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
C57BL/6 mouse lymph node cells MXfJcY12dm:|dYDwdoV{e2m4ZTDhd5NigQ>? NHmx[JEzPCCqcoO= NGnseXVKdW23bn;zeZBxemW|c3n2[UBi[3Srdnn0fUBqdiCFNUfCUE83KG2xdYPlJIx6dXCqIH7v[IUh[2WubIOgZYZ1\XJiMkSgbJJ{KGK7IF3UWEBie3OjeTygTWM2OCB;IECuOUDPxE1w NGHrZ|E9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUi3NVg1PCd-Mkm4O|E5PDR:L3G+
HuH7 M3iwbmFvfGm4aYLhcEBie3OjeR?= MVKzJIRigXN? M3vBWGFvfGm4aYLhcEBi[3Srdnn0fUBi\2GrboP0JGhEXiCpZX7veJlx\SB{YTDpcoZm[3SnZDDpckBpfW2jbjDIeWg4KGOnbHzzJIFnfGW{IEOg[IF6eyCkeTDkeYFtNWeubzDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZktKEWFNUCgQUAxNjd5MzFOwG0v Mn:0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzByN{S3PVUoRjNyMEe0O|k2RC:jPh?=
MT4 NXrtSIV3S3m2b4TvfIlkcXS7IHHzd4F6 NETZTpE1KHSxIEWg[IF6ew>? MoD3R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUXQ1KGOnbHzzJIF{e2W|c3XkJIF{KHKnZIXjeIlwdiCrbjDj[YxtKH[rYXLpcIl1gSCjZoTldkA1KHSxIEWg[IF6eyCkeTDj[YxtNXSrdHXyJIdtdyCjc4PhfUwhS0N3MDC9JFUvPjB6IN88UU4> NWjwPFhPRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{CwO|Q4QTVpPkOwNFc1Pzl3PD;hQi=>

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
Phospho-AKT1 / AKT1 / PTEN / Phospho-BAD / BAD / Procaspase-3; 

PubMed: 12644839     


Western blot analysis of phospho-AKT1, AKT1, PTEN, phospho-BAD, BAD and procaspase-3 expression in HepG2 cells treated with cyclosporin A (CA, 10 μm) and/or Taxol (Tx, 0.1 μm).

Cyp-D / AIF / β-actin; 

PubMed: 29328412     


Western blot analysis of protein expression levels of Cyp-D and AIF in the spinal cord. *P<0.05, **P<0.01, ***P<0.001. SCI, spinal cord injury; CsA, cyclosporin A; Cyp-D, cyclophilin-D; AIF, apoptosis-inducing factor.

IL-8 / MCP-1; 

PubMed: 9602633     


Representative northern blots revealing the effects of dexamethasone (DEX) and cyclosporin A (CSA) on rIL-1β induced (20 ng/ml) IL-8 and MCP-1 mRNA expression in human orbital fibroblasts at 24 hours. Equivalent total cellular RNA loading per lane is demonstrated by the electrophoretic profile (below) of 18s and 28s rRNA in all lanes, except the high dose CSA lane in which cell death occurred from cyclosporin toxicity.

Actin / Smac; 

PubMed: 12427831     


Regulation of Aβ25–35-induced Smac release from mitochondria in CECs. CECs were treated with 25 μm Aβ25–35 in the presence of cyclosporin A (B) at indicated concentrations, and cytosolic fractions were analyzed by immunoblotting with anti-Smac antibody. Cyclosporin A inhibited Smac release.

β-actin / FIPV-N; 

PubMed: 22546085     


Cyclosporin A suppresses FIPV replication in fcwf-4 cells. (B) Western blots of cells incubated with various concentrations of CsA. Lanes show total cellular proteins resolved by electrophoresis. Effects of CsA were assessed using monoclonal anti-FIPV-N and anti-β-actin primary antibodies.

12644839 29328412 9602633 12427831 22546085
Growth inhibition assay
NPC death; 

PubMed: 20181586     


Cyclosporin A (CsA) enhanced NPC survival. A, Significantly fewer cyclosporin A-treated NPCs die over 3 d compared with control NPCs (p < 0.05).

20181586
IHC
Th22 / Th17 / Th1 / M1 / Th2; 

PubMed: 30916387     


(a) Percentage of pro‐ and anti‐inflammatory cells in graft biopsies from kidney transplant recipients (KTR) under belatacept or cyclosporin A treatment. Interleukin (IL)‐22‐, CD4/IL‐17A‐, CD4/interferon (IFN)‐γ‐, CD16/tumor necrosis factor (TNF)‐α‐ and CD4/IL‐4‐expressing cells in graft biopsies. Belatacept: n = 23 biopsies and cyclosporin A: n = 10 biopsies. Arrows depict double immunoreactive cells (in burgundy). Arrowhead shows a CD4+ T cell (in brown). Results are expressed as median (black line), mean (red line), and 5th/95th percentiles. Statistical analysis: one‐way analysis of variance; Dunn’s method.

Tregs / Bregs / pDCs / M2; 

PubMed: 30916387     


(b) Percentage of regulatory cells in graft biopsies from kidney transplant recipients (KTR) under belatacept or cyclosporin A treatment. CD25/forkhead box protein 3 (FoxP3)‐, CD20/IL‐10‐, CD123/L‐kynurenine‐ and CD163/IL‐10‐expressing cells in graft biopsies. Arrows depict double immunoreactive cells (in burgundy). Arrowhead shows a CD25+ T cell (in pink). Belatacept: n = 23 biopsies and cyclosporin A: n = 10 biopsies. Results are expressed as median (black line), mean (red line), and 5th/95th percentiles. Statistical analysis: one‐way analysis of variance; Dunn’s method.

Ki 67 / Fas-FasL; 

PubMed: 30916387     


(c) Percentage of senescent, apoptotic and proliferating cells in graft biopsies from KTR under belatacept or cyclosporin A treatment. Ki‐67‐, p16INK4α‐ and FAS/FASL‐expressing cells in graft biopsies. Photomicrographs on the left shows the expression of Ki67. Photomicrographs on the right depict the apoptotic cells. Belatacept: n = 23 biopsies and cyclosporin A: n = 10 biopsies. Results are expressed as median (black line), mean (red line) and 5th/95th percentiles. Statistical analysis: one‐way analysis of variance; Dunn’s method.

IFN-γ / TNF-α; 

PubMed: 10931158     


Effect of cyclosporin A (CsA) on expression of IFN-γ and tumour necrosis factor-alpha (TNF-α). (a) Renal expression of IFN-γ in a rat with chronic serum sickness (CSS). (b) IFN-γ in a rat treated with CsA. (c) TNF-α in rat with CSS. (d) TNF-α expression in a CsA-treated rat.

WT-PCLS / FXRKO-PCLS; 

PubMed: 26482353     


Histological analysis of liver slices treated with cyclosporin A (CsA). WT-PCLS (a-d) were cultured for 24 and 48 h in the presence of DMSO (a and c) or 40 μM CsA (b and d). FXRKO-PCLS (e-h) were cultured for 24 and 48 h in the presence of DMSO (e and g) or 40 μM CsA (f and h).

30916387 10931158 26482353
Immunofluorescence
Human gingival fibroblast cells; 

PubMed: 27857765     


Human gingival fibroblast cells were incubated with calcium green 1 AM for 1 h and cyclosporin A (25 μM) and angiotensin II (100 μM) were added and nuclei stained with 4, 6diamidino-2-phenylindole (blue), imaging was done using an immunofluorescence microscopy under x10 (a). Time-dependent calcium intensity was measured (b). CsA: Cyclosporin A; Ang II: Angiotensin II; DAPI: 4, 6-diamidino-2-phenylindole.

Human gingival fibroblast cells; 

PubMed: 27857765     


Live staining was done by incubating the human gingival fibroblast cells with calcium green 1 AM for 1 h following which cyclosporin A and angiotensin II was added and images were taken using confocal microscope under × 20 objectives (a). Histogram represents the mean fluorescence intensity (b). CsA: Cyclosporin A; Ang II: Angiotensin II; HGF: Human gingival fibroblasts.

Calcein; 

PubMed: 23593196     


E. XR9576, verapamil, and cyclosporin A enhanced calcein fluorescence in KB-V1 cells. KB-V1 cells treated with the indicated compounds and 1 µM calcein AM were imaged 1 hour later. The phase-contrast and fluorescent images were merged and displayed (size bar = 100 µm).

Rhod-Dex / Calcein; 

PubMed: 20584761     


Lack of protection by cyclosporin A against acetaminophen-induced lysosomal breakdown and calcein quenching. Mouse hepatocytes were loaded with rhodamine-dextran and calcein, as described in Figure 6 and treated with acetaminophen (AAP) in the presence of fructose plus glycine and cyclosporin A (CsA, 1μM).

cadherin-9 / vimentin; 

PubMed: 17668045     


To induce a transition of renal epithelial cells into a spindle-shaped mesenchymal cell type, the epithelial TK 163 cells were cultured for 48 hours in different concentrations (0, 4.2 and 42 µM) of cyclosporin-A (CsA). EMT could be observed by phase contrast microscopy. Immunofluorescence staining revealed that without CsA no signals for cadherin-9 and only weak signal for vimentin could be observed. Induction of EMT by CsA led to a strong up-regulation of both vimentin and cadherin-9 expression.

27857765 23593196 20584761 17668045
体内研究 Cyclosporin A是一种免疫抑制剂,小鼠,大鼠,和荷兰猪经非肠道给药或者口服给药都有效[6],临床上用于器官移植中预防免疫排斥。[7]

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验:[3]
- 合并

磷酸酶试验:

纯化的牛脑钙调磷酸酶和钙调蛋白是购买的。含纯化酶的反应混合物包含100 nM 钙调磷酸酶,100 nM 钙调蛋白,以及5 μM 32P-标记磷酸化多肽,60 μl (总体积) 试验缓冲液包含20 mM Tris (pH 8),100 mM NaCI,6 mM MgCl2,0.5 mM 二硫苏糖醇, 每毫升0.1毫克牛血清白蛋白,以及0.1 mM CaCl2或5 mM EGTA。含细胞裂解物的反应混合物包含20 μl of未稀释裂解物, 5 μM 32P-标记的磷酸肽,和40 μl 试验缓冲液。反应混合物包含50 μM 多肽412或413和/或 500 nM冈田酸,一种磷酸酶1和2A的特异性抑制剂; 500 nM 冈田酸足以抑制Ca2+-不依赖性磷酸酶,而更高浓度时也会部分抑制Ca2+-依赖性的活性。30°C下培育15分钟,加入0.5 ml包含5% 三氯乙酸的100 mM 磷酸钾缓冲液(pH 7.0)终止反应。Dowex阳离子交换色谱分离无机磷酸盐,用闪烁计数测定数量。
细胞实验:[3]
- 合并
  • Cell lines: Jurkat细胞(无性繁殖J77)
  • Concentrations: ~100 nM
  • Incubation Time: 1小时
  • Method: 免疫抑制剂以细胞治疗浓度的1000倍溶于乙醇。细胞(106)悬浮于微量离心管1ml完全培养基中;1 μl乙醇或者Cyclosporin A乙醇溶液加入反应液中,细胞在37°C下培育1小时。细胞在冰浴下用1ml PBS洗两次,在50μl低渗缓冲液中裂解,缓冲液每毫升包含50 mM Tris (pH 7.5); 0.1 mM EGTA; 1 mM EDTA; 0.5 mM二硫苏糖醇; 以及50 微克苯甲基磺酰氯,50 微克胰蛋白酶抑制剂,5微克亮抑酶肽,和5 微克抑肽酶。裂解液用液氮冷冻,再在30°C下融化,循环3次,随后在 4°C下以12,000×g离心10分钟。
    (Only for Reference)
动物实验:[6]
- 合并
  • Animal Models: 大鼠
  • Dosages: 45毫克/千克
  • Administration: 口服
    (Only for Reference)

溶解度 (25°C)

体外 DMSO 100 mg/mL warmed (83.15 mM)
Water Insoluble
Ethanol ''''100 mg/mL warmed
体内 从左到右依次将纯溶剂加入产品,现配现用(数据来自Selleck实验检测而非文献):
2% DMSO+30% PEG 300+5% Tween 80+ddH2O
5mg/mL

* 溶解度检测是由Selleck技术部门检测的,可能会和文献中提供的溶解度有所差异,这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据

分子量 1202.61
化学式

C62H111N11O12

CAS号 59865-13-3
储存条件 粉状
溶于溶剂
别名 Cyclosporine A, Cyclosporine, Ciclosporin, CsA

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % ddH2O
计算重置

计算器

摩尔浓度计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

  • 质量
    浓度
    体积
    分子量

*在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。

稀释计算器

稀释计算器

用本工具协助配置特定浓度的溶液,使用的计算公式为:

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入 输出 )

  • C1
    V1
    C2
    V2

在配置溶液时,请务必参考Selleck产品标签上、SDS / COA(可在Selleck的产品页面获得)批次特异的分子量使用本工具。.

连续稀释计算器方程

  • 连续稀释

  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
分子量计算器

分子量计算器

通过输入化合物的化学式来计算其分子量:

总分子量:g/mol

注:化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量 浓度 体积 分子量
计算

临床试验信息

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT05056779 Not yet recruiting Drug: Nemolizumab|Drug: CD14152 placebo Moderate-to-severe Atopic Dermatitis Galderma R&D January 2022 Phase 3
NCT04989686 Not yet recruiting Other: Microsampling Immunosuppression Children''s Hospital of Philadelphia December 2021 --
NCT04023760 Completed Drug: Apixaban Pharmacokinetics|Kidney Transplant|Lung Transplant University of Saskatchewan|Saskatchewan Health Research Foundation|Lung Association of Saskatchewan June 26 2019 Phase 4
NCT03865888 Completed Drug: Cyclosporins|Drug: Tacrolimus Dry Eye|Sjogren Syndrome Pavly Moawd|Cairo University October 30 2018 Phase 3

技术支持

在订购、运输、储存和使用我们的产品的任何阶段,您遇到的任何问题,均可以通过拨打我们的热线电话400-668-6834,或者技术支持邮箱tech@selleck.cn,直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题,请给我们留言。

  • * 必填项

常见问题及建议解决方法

  • 问题 1:

    What is the difference between S2286 (cyclosporin A) and S1514 (cyclosporin)?

  • 回答:

    Cyclosporine is a mixture of Cyclosporine A, derivatives of Cyclosporine A, salts of Cyclosporine A. Cyclosporine A is an especially useful Cyclosporine component.

Tags: 购买Cyclosporin A (NSC 290193) | Cyclosporin A (NSC 290193)供应商 | 采购Cyclosporin A (NSC 290193) | Cyclosporin A (NSC 290193)价格 | Cyclosporin A (NSC 290193)生产 | 订购Cyclosporin A (NSC 290193) | Cyclosporin A (NSC 290193)代理商
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID